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Abstract 
Aldehyde dehydrogenase (ALDH) is an enzyme that regulates differentiation during 
pancreatic development, but determining the role of ALDH during endocrine differentiation 
is not well defined. The purpose of this study was to characterize transcription factors (TFs) 
and putative stem cell surface markers in ALDHhi or ALDHlo populations of the human fetal 
pancreas (18-22 weeks of age), and examine their expansion and differentiation in vitro and 
in vivo. Cell surface marker analysis demonstrated high co-localization of the stem cell 
marker CD133 with ALDHhi cells. ALDHhi cells also contained higher expression of islet-
associated TFs and insulin. Expansion of sorted ALDHhi cells resulted in down-regulation of 
endocrine TF genes, yet differentiated ALDHhi islet-like clusters partially restored TF 
mRNA, but not protein, levels. Sorted cells transplanted into nude mice showed increased 
vascularization in ALDHlo fibrin gels. In summary, this study demonstrated that ALDHhi 
cells represent an endocrine progenitor pool important for β-cell differentiation.  
Key Words: Aldehyde dehydrogenase, CD133, β-cell development, FACS, human fetal 
pancreas 
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Chapter 1 – Introduction 
1.1       Significance of Study 
The transplantation of functioning and glucose-sensitive β-cells into type I diabetic 
patients has been extensively examined for the restoration of endogenous insulin 
secretion and function. Although limited success is seen with transplanting existing donor 
islets (Ryan et al. 2002), recent interest has been invested in directed differentiation of 
uncommitted stem and progenitor cells towards functioning endocrine cells (D’Amour et 
al. 2006). Successfully producing cells that secrete insulin in response to blood glucose 
fluctuations requires the detailed examination of factors that give rise to β-cells in vivo. 
Once these developmental endocrine precursors have been identified and isolated, they 
can be expanded and matured in vitro for further analysis regarding their suitability for 
transplantation. 
The work examined in this thesis provides insight into a putative stem cell marker, 
ALDH, that has been previously characterized in the developing human pancreas, and 
shown to influence endocrine cell development during the 1st and 2nd trimesters of 
pregnancy (Li et al. 2014). Expression of endocrine-committing transcription factors 
during development are also necessary, so the overlap of transcription factors within cells 
expressing putative stem markers needs to be determined in order to establish their 
suitability for further research addressing β-cell generation. This project contributes to the 
field of β-cell development by implementing fluorescence-activated cell sorting (FACS) 
for the separation of distinct putative stem cell populations within the human fetal 
pancreas. Furthermore, sorted cells are characterized and analyzed both in vitro and in 
vivo to determine the functions of the isolated populations. 
1.2 Overview of the pancreas and diabetes mellitus 
The pancreas is a secretory organ of the digestive system that contains two distinctive 
functioning units: the exocrine tissue (~98% of the total pancreas) and endocrine tissue 
(~2% of the pancreas). The exocrine portion is composed of acinar cells, which produce 
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and release digestive enzymes, and ductal cells, responsible for transporting these 
enzymes to the duodenum for the breakdown of the bolus. The endocrine cells are located 
within clusters known as the islets of Langerhans, and are heavily vascularized to allow 
for the release of glucose-regulating hormones into the blood stream. Islets found within 
the pancreas are composed of the following cell types and corresponding secreted 
hormones: α-cells (glucagon), β-cells (insulin), δ-cells (somatostatin), γ or PP cells 
(pancreatic polypeptide, or PP), and ε-cells (ghrelin). Human and murine islets differ in 
the morphology and composition of the islets; while murine islets have a higher 
percentage of β-cells that cluster in the center of the islet, human islets have higher 
contact between α-cells and β-cells (Brissova et al. 2005, Cabrera et al. 2006). Insulin 
production and secretion is critical for lowering glucose in circulation via a biphasic 
secretion response from the β-cells. Problems encountered with the reuptake of glucose, 
regulated by the glucose transporter class (GLUT) (Wood and Trayhurn. 2003), and 
production or secretion of insulin is categorized as diabetes mellitus. This disease 
manifests itself as two common diagnoses, type I or type II, based on the pathology of the 
disease. Type I diabetes is caused by autoimmune destruction of up to 90% of β-cells in 
the pancreas, and patients require an exogenous source of insulin to meet metabolic 
demands and avoid ketoacidosis (Shapiro et al. 2000). Type II diabetes is generally 
associated with insulin resistance across tissues accompanied by insulin dysfunction in β-
cells (Masini et al. 2012), resulting in the inability to clear glucose from the circulating 
blood stream. These patients are typically able to improve glucose levels by exercise and 
diet changes.  
In order to restore endogenous insulin production and secretion in type I diabetic patients, 
the Edmonton Protocol has been designed (Shapiro et al. 2000). This involves the 
transplantation of isolated islets from donor pancreata into the hepatic portal vein of 
immunosuppressed patients. Although these patients experience exogenous insulin 
dependence for the first year after these procedures, a low supply of cadaveric donors and 
transplantation complications due to aged islets from donors (Street et al. 2004) limit the 
use of this technique. Because of this, there is interest in investigating the formation of 
fully differentiated islets from programmed undifferentiated cells for the treatment of 
type I diabetic patients. By generating fully differentiated islets from a source that can 
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yield a large number of cells, it can be possible to correct the complications seen using 
cadaveric islets. In order to understand the developmental pathway of endocrine cells in 
the pancreas, the architecture of islets in vivo and specific factors that give rise to 
hormone-producing islet cells must be determined. 
1.3 Development of the human fetal pancreas 
The architecture of the human pancreas changes dramatically during the course of 
development. Fetal age, which is assigned two weeks later than the gestational age 
(marked at the beginning of the previous menstrual cycle), will be used throughout this 
section to describe pancreatic development. The pancreas first develops between 3 to 4 
weeks of fetal age as two separate buds off of the duodenum, labeled the dorsal 
pancreatic bud and the ventral pancreatic bud (Piper et al. 2004, Jennings et al. 2013). 
The dorsal and ventral pancreatic buds fuse at approximately 7 to 8 weeks of fetal age to 
form the single immature pancreas (Piper et al. 2004), and the dorsal duct is normally lost 
in favour of the ventral pancreatic duct (Kamisawa. 2004). The pancreatic composition at 
7 to 8 weeks of fetal age contains a high percentage of mesenchymal cells, with simple 
ductal structures and interspersed epithelial clusters (containing emerging endocrine 
cells) scattered throughout the mesenchyme (Lyttle et al. 2008, Sarkar et al. 2008). The 
ductal cell marker cytokeratin 19 (CK19) is also expressed throughout the epithelial cell 
clusters early in development before expression is restricted to duct-like structures 
(Sarkar et al. 2008). Around this time, insulin+ cells are detected in the pancreas, and this 
is followed with glucagon+ cells emerging at 7 to 8.5 weeks of fetal age (Piper et al. 
2004, Jeon et al. 2009). Somatostatin+ cells are seen as early as 8 to 8.5 weeks of fetal 
age, while PP+ cells do not emerge until 10 weeks of fetal age (Piper et al. 2004, Jeon et 
al. 2009). Ghrelin+ single cells are present in the pancreas at 11 weeks of fetal age 
(Andralojc et al. 2009). The grouping of insulin+ and glucagon+ cells close to one another 
is first reported at 10 weeks of fetal age, but prominent endocrine clustering of insulin+ 
and glucagon+ cells with somatostatin+ and PP+ cells is not observed until 15 weeks of 
fetal age (Jeon et al. 2009). Ghrelin+ cells are not observed in the islets until 19 weeks of 
fetal age (Andralojc et al. 2009). These developing islets are found close to the ductal 
structures, and CK19 expression decreases in islets as they mature; CK19 staining is 
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weak in islets from 16 to 22 weeks of fetal age, and islets are completely negative for 
CK19 from 22 to 39 weeks of fetal age (Bouwens et al. 1997). Beginning at 8 weeks of 
fetal age, staining for vasculature could be seen in proximity to the forming endocrine 
cell clusters (Sarkar et al. 2008). These vessels invade islet clusters around 12 weeks of 
fetal age (Piper et al. 2004), which is necessary for hormone transport in mature islets. 
CEL, an indicator of early acinar cells, first appears in the epithelium at 9 weeks of fetal 
age (Sarkar et al. 2008). Lobular cell structures form during 12 to 18 weeks of fetal age 
(Adda et al. 1984), yet staining for amylase (an acinar secretory enzyme) emerges later 
on in the 2nd trimester of pregnancy (Sarkar et al. 2008). The weight of the human fetal 
pancreas increases to approximately 337 mg at 21 weeks of fetal age (compared to 9 mg 
at 8 weeks of fetal age), and the masses of islet cells, composed primarily of α-cells and 
β-cells, express transcription factors indicative of maturing islets (low NGN3 and high 
co-localization of PDX-1 and Insulin) (Lyttle et al. 2008).  
1.4 TFs associated with endocrine cell differentiation 
Successful commitment to islet and β-cell fate requires sequential expression of 
transcription factors during development of the human pancreas (Figure 1.1) (Lyttle et al. 
2008). For endocrine cell commitment (and specifically β-cell fate), endoderm cells first 
up-regulate transcription factors necessary for pancreas development. PTF1α and PDX-1 
are early pancreatic progenitor transcription factors expressed in the developing 
pancreatic buds and are required for pancreatic development from the duodenum (Offield 
et al. 1996, Kawaguchi et al. 2002, Burlison et al. 2008). SOX9, another pancreatic 
progenitor factor found during early development, maintains the progenitor cell pool 
during development and plays a prominent role during cell lineage determination via 
Notch activity (Lynn et al. 2007, McDonald et al. 2009, Shih et al. 2012). The cell type 
that develops from the pancreatic epithelium relies on activation of the Notch receptor, 
which increases the precursor transcription factor HES-1 (Apelqvist et al. 1999, Kopinke 
et al. 2011). HES-1 inhibits NGN3, the endocrine precursor transcription factor, during 
early stages of development (Jensen et al. 2000a and 2000b, Gu et al. 2002, Fujikura et 
al. 2006), but decreased Notch activation later on in development leads to expression of 
NGN3 (Shih et al. 2012). Once cells are committed to endocrine fate, there is further 
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regulation of transcription factor downstream of NGN3 required for islet cell 
commitment and function, including PAX6 (Sander et al. 1997), ISL1 (Du et al. 2009), 
and NKX6.1 (Schaffer et al. 2013). A detailed description of important transcription 
factors examined throughout this project is provided below. 
1.4.1    SOX9 
SRY (sex determining region Y)-box 9 (SOX9) is part of the high-mobility binding group 
domain family, and is recognized as a pancreatic progenitor transcription factor, as well 
as a marker of small intestine progenitors (Formeister et al. 2009, Belo et al. 2013). It is 
found upstream of key transcription factors responsible for commitment to pancreatic cell 
fate, and contributes to the progenitor pool during pancreatic development (Seymour et 
al. 2007 and 2012). In the developing human pancreas, strong SOX9 staining is first 
present in the immature pancreatic buds 32 days after conception (between 4 to 5 weeks 
of fetal age); however SOX9 decreases with age, with a noticeable drop at 17 to18 weeks 
of fetal age (McDonald et al. 2012). Although inactivating Sox9 expression in the 
pancreas reduces Pdx-1 expression levels, pancreatic tissue still develops (Seymour et al. 
2007, Dubois et al. 2011), indicating that multiple TFs are responsible for pancreas 
organogenesis. Co-localization of SOX9 with NGN3+, insulin+, and glucagon+ cells is 
seen at 8 to 11 weeks of fetal age, but a dramatic loss of SOX9 in these endocrine cells is 
observed at 20 to 21 weeks of fetal age (McDonald et al. 2012), indicating that SOX9 
contributes to endocrine cell formation during the early stages of fetal development. At 
later stages of pancreatic development (20 to 21 weeks of fetal age in human), SOX9+ 
cells are primarily found in the pancreatic ducts (Shih et al. 2012, McDonald et al. 2012). 
This observation correlated with examined adult murine pancreata 8 weeks after birth, 
where Sox9 is retained in ductal cells (Furuyama et al. 2011). Sox9 also contributes to the 
exocrine compartment, as seen in the developing murine pancreas (Kopp et al. 2011), 
indicating that this TF is not restricted to a specific pancreatic cell lineage during 
development. Campomelic dysplasia (CD) patients, diagnosed with SOX9   
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Figure 1.1 Pathway of transcription factor activation for β-cell induction. The 
diagram above is a simplified pathway of β-cell differentiation that focuses on key TF 
expression mentioned in this thesis. The information in this figure is modified from 
results found in Lyttle et al. (2008), McDonald et al. (2012), and Riedel et al. (2012). 
 
 
 
7 
 
haploinsufficiency, demonstrate reduced islet cell size and dysfunction, with no 
observable effect on the surrounding exocrine tissue (Piper et al. 2002). Therefore, dose 
dependent studies have been conducted to focus on this observed effect. Developing 
murine pancreata with a ~50% decrease in Sox9 expression supported what is seen in CD 
patients, with normal pancreatic organogenesis but reduced islet size and number of 
endocrine cell precursors (Seymour et al. 2008). This is further supported by the siRNA 
knockdown of SOX9 gene in human fetal islet epithelial cell clusters (~50% reduction in 
SOX9), where a significant reduction of NGN3 and Insulin mRNA expression was 
observed (McDonald et al. 2012). Overall, these studies indicate that SOX9 is essential 
for maintaining the pancreatic progenitor pool and important for regulating the early 
development of endocrine islet cells. 
1.4.2 PDX-1 
Pancreatic and duodenal homeobox 1 (PDX-1) is a transcription factor that is part of the 
homeodomain-containing family (Kaneto et al. 2008) and regulates the cell fate of 
pancreatic and duodenal cells (Burlison et al. 2008). Although the exocrine transcription 
factor Ptf1a is important for endoderm commitment to the pancreatic fate, PDX-1 has 
been identified as an important transcription factor for endocrine cell development 
(Burlison et al. 2008, Lyttle et al. 2008). It first appears in the developing human 
pancreas at approximately 4 weeks of fetal age along the foregut area that is reported as 
the precursor to the mature duodenum and pancreas (Jennings et al. 2013). PDX-1 is also 
found after the dorsal and ventral buds fuse in the developing human pancreas at 7 weeks 
of fetal age (Lyttle et al., 2008, Sarkar et al. 2008). The endocrine, acinar, and ductal cells 
of the pancreas all arise from Pdx-1+ cells (Gu et al. 2002), emphasizing the important 
role that Pdx-1 plays during normal murine pancreas development. PDX-1 expression is 
also necessary in human embryonic stem cells in order to successfully produce endocrine 
cells (Johannesson et al. 2009). Furthermore, Pdx-1 expression is seen earlier than Ngn3 
expression (Villasenor et al. 2008), indicating its upstream effects on endocrine cell 
differentiation. However, PDX-1 and NGN3 co-localization decreases with age in the 
developing fetal pancreas (Lyttle et al. 2008), which could represent a progenitor pool 
becoming committed to the endocrine cell fate. In addition, PDX-1 co-localization 
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decreases in CK19+ cells, increases in insulin+ and somatostatin+ cells, and is not present 
in committed glucagon+ cells during human fetal development (Lyttle et al. 2008), 
demonstrating specificity of this transcription factor towards distinct endocrine cell fate 
in later stages of development.  
1.4.3 NGN3 
Neurogenin 3 (NGN3) is a basic helix-loop-helix transcription factor (Jensen et al. 
2000b) that commits pancreatic cells to the endocrine islet precursor cell fate (Gu et al. 
2002, Gradwohl et al. 2000). It is downstream of the Notch receptor, which under normal 
circumstance activates the exocrine-promoting transcription factor HES-1 and inhibits 
NGN3 expression (Dror et al. 2007). In early stages of human fetal pancreatic 
development (8 to 11 weeks of fetal age), NGN3+ cells co-localize frequently with PDX-
1+, insulin+, and glucagon+ cells; this co-expression decreases in pancreata at later stages 
of development (20 to 21 weeks of fetal age) (Lyttle et al. 2008), suggesting an important 
role for this factor during early initial endocrine commitment. However, recent 
information from human patients with NGN3 biallelic deletions reported that patients still 
produced insulin (Rubio-Cabezas et al. 2014). This indicates that there is an alternative 
differentiation pathway for insulin-secreting cells that does not require NGN3 expression 
early on in human development. Ngn3+ cells in the developing murine pancreas have 
been shown to co-localize with Sox9+ ductal cells, demonstrating an endocrine precursor 
rich area during development (Lynn et al. 2007). In addition, murine development studies 
have identified that Ngn3 is downstream of Pdx-1 (Oliver-Krasinski et al. 2009), 
indicating that endocrine cells emerge after initial pancreatic commitment. Further 
experiments in murine pancreata confirm a lack of Ngn3 expression in acinar cells during 
development, and that Ngn3 was absent from the pancreas of adult mice (Gradwohl et al. 
2000).  
1.4.4 NKX2.2 and NKX6.1 
NK2 homeobox 2 (NKX2.2) is a transcription factor that contributes to endocrine cell 
fate. Nkx2.2 is seen throughout the dorsal pancreatic bud in early stage murine embryos, 
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but becomes restricted to the endocrine cells in later stage embryos (Sussel et al. 1998). 
Murine pancreata analyzed right before birth show that there is high co-localization of 
Nkx2.2 with insulin+ and glucagon+ cells, but not somatostatin+ cells (Sussel et al. 1998), 
suggesting that Nkx2.2 activity is only necessary for specific endocrine cell development. 
Unlike Ngn3, Nkx2.2 is still found within the endocrine cells of the islets in adult murine 
pancreata (Sussel et al. 1998), indicating that this transcription factor could be used to 
isolate certain mature islet cells. In addition, Nkx2.2 affects β-cell functionality and 
insulin secretion in adult murine pancreata (Doyle and Sussel. 2007). 
NK6 homeobox 1 (NKX6.1) is another transcription factor of the same homeobox gene 
group that is specifically associated with β-cell commitment (Sander et al. 2000). 
Research in the embryonic murine pancreas shows that early on in development (e10.5), 
Nkx6.1 is found in multipotent cells, and co-localizes with the acinar-committing TF 
Ptf1α (Schaffer et al. 2010), before becoming confined to the endocrine-producing area 
of the pancreas along the ductal cells after birth (Schaffer et al. 2010, Schaffer et al. 
2013). Murine studies have demonstrated that Nkx6.1 is necessary for ensuring β-cell fate 
during development, but not other endocrine cell fates, and is not solely sufficient for β-
cell development (Schaffer et al. 2013). Similar to Nkx2.2, Nkx6.1 is present throughout 
the developing pancreas in early stage murine embryos, but becomes restricted to insulin+ 
and ductal cells in later stages (Sander et al. 2000), before finally becoming β-cell 
restricted (Schaffer et al. 2013). Parallel studies in human fetal pancreata found that 
NKX6.1 co-localizes with insulin+ cells as early as 10 weeks of fetal age, with adult 
pancreata only displaying NKX6.1 co-localization in β-cells (Lyttle et al. 2008, Riedel et 
al. 2012).  
1.4.5 ISL1 
Islet 1 (ISL1) is a transcription factor in the LIM homeodomain family (Ahlgren et al. 
1997) that has been linked to both mesenchymal and progenitor cells of the pancreas 
(Eberhardt et al. 2006). Isl1 cell expression affects all endocrine cells in the pancreas 
(Eberhardt et al. 2006, Andralojc et al. 2009). Embryonic mice with a mutation of Isl1 
did not develop mesenchyme in the dorsal portion of the pancreas, and the isolated tissue 
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could not produce any of the islet endocrine cells from the epithelial buds (Ahlgren et al. 
1997). Additionally, Isl1 is present in islet cells of the adult pancreas and have been 
shown to increase proliferation and maintain glucose tolerance in β-cells (Guo et al. 
2011, Ediger et al. 2014), revealing that Isl1 modulates islet cells in the adult pancreas 
and is not restricted to pancreatic development. Mutations in Isl1 expression reduces 
Pax6+ cells in the postnatal murine pancreas, and is responsible for regulating the 
transcription of MafA, another transcription factor needed to establish proper glucose 
sensing in β-cells (Du et al. 2009).  
1.4.6 PAX4 and PAX6 
Paired box gene 4 (PAX4) is a transcription factor that, although not analyzed in this 
project, is heavily associated with β-cell development. It is directly antagonistic to the α- 
cell transcription factor Arx (Collombat et al. 2003 and 2005), and has been demonstrated 
to increase insulin+ cells during differentiation of mESCs programmed with vectors 
containing that specific gene (Blyszczuk et al. 2003). Additionally, PAX4 overexpression 
in adult rat islets resulted in increased β-cell proliferation (Brun et al. 2004).  
Unlike PAX4, Paired box gene 6 (PAX6) is a transcription factor that is associated with 
insulin+ and glucagon+ cells during early endocrine cell development (Sander et al. 1997). 
However, studies of adult murine pancreata demonstrate that Pax6+ cells are found in all 
endocrine cell types and regulates via their hormone gene promoters (Sander et al. 1997). 
Pax6 mutant mice do not develop glucagon+ cells and display abnormal islets (St-Onge et 
al. 1997), suggesting that PAX6 is important for α-cell development and proper islet cell 
formation. 
1.5 Pancreatic stem cells and endocrine cell differentiation 
The production of new endocrine cells in the pancreas is a debated topic, with evidence 
of new adult β-cells arising from replication instead of stem cells as a possible source 
(Dor et al. 2004). Therefore, establishing stem cell sources within the pancreas is 
important for further understanding islet cell repopulation. Uncommitted progenitor cell 
pools are present during pancreatic development and organ maturation, while possible 
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pools of stem cells have been reported throughout the adult pancreas. This section will 
focus on the developing and adult human pancreas, and will discuss stem cell 
contributions to specific pancreatic cell fate. 
1.5.1 Stem cell sources in the embryonic and fetal pancreas 
The differentiation of immature cells in the fetal pancreas has been studied extensively to 
explain the relationship of precursor cells during endocrine cell commitment. Precursor 
cells are important for the overall development of the pancreas, as seen in the reduction 
of Pdx-1+ multipotent cells during murine development (Stanger et al. 2007).  Since the 
maturation of the pancreatic tissue occurs throughout organogenesis, pancreatic cells 
readily express transcription factors that mark an uncommitted phenotype, including 
SOX9, PDX-1, and NKX6.1 (Lyttle et al. 2008, McDonald et al. 2012, Pan and Brissova. 
2014); this indicates additional multipotency throughout the developing pancreas than 
what is seen in the adult structures. Nevertheless, examining the fetal pancreas for known 
stem cell markers (discussed in the following sections) assists with precursor 
identification. 
Although in vitro stem cells sources do not capture in vivo pancreatic organogenesis, the 
use of embryonic stem cells, both human (hESCs) and murine (mESCs), are important 
for determining transcription factors and markers that link commitment of the developing 
pancreas to specific cell function (Kelly et al. 2011). Committing ESCs to definitive 
endoderm, characterized by the successful expression of Pdx-1, allows for accessible 
programming of this layer towards different cell fates in vitro (Micallef et al. 2005, 
D’Amour et al. 2006, Micallef et al. 2007). Further treatments of Pdx-1+ murine and 
human ESCs with stage-dependent protocols, designed to guide undifferentiated cells 
towards a committed pancreatic cell fate, have resulted in the production of endocrine 
cells in vitro (Jiang et al. 2007, Micallef et al. 2007). Additionally, hESCs geared towards 
β-cell fate and composed of a high population of NKX6.1+ cells are able to mature into 
insulin-secreting cells in vivo and alleviate diabetic symptoms when transplanted into 
STZ mice (Rezania et al. 2013), indicating the functional applications of this stem cell 
source.  
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1.5.2 Stem cell sources in the adult pancreas 
The adult pancreas is a fully matured organ with functioning differentiated cells, though 
it has been noted that progenitor sites that contribute to endocrine cell development 
during fetal organogenesis lose their ability in the adult pancreas (Solar et al. 2009, Kopp 
et al. 2011). As a result, the isolation of cells with progenitor features from this source 
has been thoroughly examined to determine if there is an undifferentiated population that 
contributes towards the islet cell population. Indeed, adult murine islet and ductal cells 
were able to separately form colonies of pancreas-derived multipotent cell clusters 
(Seaberg et al. 2004), showing that there is potential for restoring undifferentiated cells in 
committed lineages. One identified bulk source is the epithelial compartment of the 
pancreas (Hao et al. 2006). Successful isolation of epithelial cells from islet and 
mesenchymal cells resulted in the ability to use this population in vitro as a stem cell 
source for endocrine cell production (Hao et al. 2006). In contrast, mesenchymal cells 
isolated from pancreatic islets expressed ISL1 and were able to form c-peptide-producing 
cell clusters under differentiation conditions, indicating that these cells are a pancreatic 
source capable of producing endocrine cells (Eberhardt et al. 2006). The ductal 
epithelium of the adult pancreas, identified as a progenitor pool in fetal pancreata, may 
also represent another source that contributes to new islets (Gao et al. 2003). Cells that 
exhibit stem cell traits have been previously isolated from isolated adult human 
pancreatic ducts and demonstrated endocrine cell lineage in vitro (Lin et al. 2006). 
Furthermore, adult patients suffering from nesidioblastosis are able to generate insulin+ 
cells from pancreatic ductal cells (Gmyr et al. 2000), demonstrating lineage plasticity and 
the potential for β-cell production in vivo. Isolated adult murine ductal cells also display 
multipotency when cultured, and demonstrated endocrine transcription factors as well as 
guided islet differentiation (Ramiya et al. 2000). Finally, research focused on in vivo 
pancreatic duct ligation has been used to examine its effect on endocrine cell production 
during pancreatic injury, with supporting (Wang et al. 1995, Van de Casteele et al. 2014) 
and contrasting (Kopp et al. 2011, Rankin et al. 2013) evidence regarding the stimulation 
of β-cell neogenesis. Ligation drastically amplifies the presence of cells positive for the 
stem cell marker c-Kit (CD117) within the ducts (Peters et al. 2005), revealing that 
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progenitor cells can be stimulated within this tissue source. Furthermore, 
pancreatectomies in adult rats that had the pancreatic tail and most of the pancreatic head 
removed led to regeneration of the missing tissue via the ductal epithelium, again 
suggesting that the ducts contain progenitor cells capable of endocrine repair (Bonner-
Weir et al. 1993). The acinar cells from the exocrine portion of the pancreas have also 
demonstrated precursor features, as seen during the transdifferentiation of acinar-to-
ductal cells in vitro and the subsequent appearance of PDX-1, necessary for the early 
stages of islet commitment (Rooman et al. 2000). An additional cell source that has been 
reported is the pancreatic stellate cell (PSC) (Kordes et al. 2012, Lonardo et al. 2012), 
which can be located throughout the pancreas around the ductal cells (Apte et al. 2012), 
and can also be isolated from pancreatic tumours (Lonardo et al. 2012). 
Identifying multipotent cells within the developing pancreas is ideal for understanding 
the organogenesis of hormone-producing islet cells and can be utilized for 
reprogramming stem cells from multiple sources into β-cells. For the proper isolation of 
potential pancreatic islet progenitor cells that could be differentiate into islet cells, select 
surface stem cell markers must also be established. 
1.6 Surface stem cell markers 
Surface proteins located on the outer cell membrane are useful for isolating viable stem 
and progenitor cells by FACS for further analysis, since they can be tagged with 
antibodies without jeopardizing cell population. The clusters of differentiation (CD) 
markers are located on the outer membrane of cells and are commonly identified on 
hematopoietic stem and progenitor cells (Yin et al. 1997), and as a result this cell type is 
often studied for differentiation and regeneration properties. This project focused on the 
following three CD markers: CD133, CD34, and CD117 (Figure 1.2).  
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Figure 1.2 The presence of surface stem cell markers in the pancreas. CD133, CD34, 
and CD117 are not specific for one pancreatic cell lineage, and are found on multiple cell 
types throughout the development of pancreas. This figure is a summary of the studies 
described in Section 1.6, and encompasses human and murine pancreatic development 
and analysis studies.  
  
15 
 
1.6.1 CD133 
CD133 (also known as Prominin-1) is a pentaspan membrane protein surface marker 
found on multiple cell types, including the tubular cells of the kidneys (Lindgren et al 
2011), the cells of the retina (Zacchigna et al. 2009), and on hematopoietic progenitor 
cells from different cell sources (Hess et al. 2006, Barraud et al. 2007, Snippert et al. 
2009). It is also heavily associated with different forms of neoplastic cells and has been 
examined alongside ALDH to characterize and determine tumour aggressiveness 
(Alamgeer et al. 2013, Zhou et al. 2014). In addition, CD133 has recently been defined as 
an important proponent of epithelial-to-mesenchymal transition (EMT) and migration in 
neoplastic cells (Ding et al. 2012). CD133 levels in mESC are affected by the cell’s 
progression towards mature differentiation, where high levels were seen in cells that were 
committed but not yet differentiated (Kania et al. 2005). The expression of CD133 in the 
pancreas is strongly associated with ductal epithelial cells (Oshima et al. 2007, Lardon et 
al. 2008, Koblas et al. 2008, Rovira et al. 2010), and transdifferentiation of acinar cells to 
a ductal cell fate resulted in increased CD133 expression (Houbracken et al. 2011). The 
early stage human fetal pancreas has been reported to express CD133 on epithelial cells 
(Zhang et al. 2013), and this has also been reported in the developing murine pancreata 
(Hori et al. 2008). Additionally, pancreatic stellate cells (PSCs) and endothelial cells have 
been reported to express CD133 (Koblas et al. 2008, Kordes et al. 2012). Cells that 
express this marker on their surface have also been described as a precursor population 
for β-cells (Skurikhin et al. 2014). CD133 is present on the surface of Pdx-1+ epithelia in 
developing murine embryos (Hori et al. 2008), and ductal CD133+ cells in the human and 
murine fetal pancreas co-localize with NGN3 at 14 weeks of age (Sugiyama et al. 2007), 
demonstrating an endocrine precursor fate of this cell type. Expanded cells from human 
umbilical cord blood that are CD133+ also co-express PDX-1 and NGN3 (Pessina et al. 
2010), showing the potential for non-pancreatic CD133+ cells to differentiate into islet-
like cells. The contributions of CD133+ cells in giving rise to different cell fates in the 
pancreas may be age restricted, since there have been reports that adult murine pancreata 
have higher expression of acinar and endocrine cell in CD133- populations, and that 
ductal fate is propagated in CD133+ cells (Jin et al. 2013). In addition, adult human 
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pancreas cells that express CD133 do not co-localize with the stem cell markers OCT4 or 
SOX2 (Zhao et al. 2007), suggesting that CD133+ cells at this stage are associated more 
with mature ductal epithelium.  
1.6.2  CD34 
CD34 is a transmembrane protein (Simmons et al. 1992), and is most frequently 
associated with being a marker of hematopoietic stem cells (Ito et al. 2000, Hess et al. 
2004). The multipotency of this stem cell marker has been extensively researched; CD34 
cells have demonstrated the ability to reconstitute hematopoiesis and aid in the recovery 
of damaged tissue (Iwasaki et al. 2006). Although it is not commonly associated with the 
pancreas, the presence of CD34 has been previously examined throughout the tissue. 
Cells close to the ductal cells of the rat pancreas showed CD34 expression, and CD34 
was seen dispersed throughout the islet (Joanette et al. 2004). CD34 has also been 
identified on fibrocytes surrounding the ductal and acinar cells of the adult human 
pancreas (Barth et al. 2002). It has also been identified as a marker of developing 
vasculature in the islets of the human fetal pancreas (Piper et al. 2004) and in the 
mesenchymal tissue early on in development (Castaing et al. 2005). In the bovine 
pancreas, CD34 is present on α- cells of the islets (Merkwitz et al. 2011). Although CD34 
is recognized as a marker for hematopoietic stem cells, there was no co-localization seen 
in cells expressing the stem cell markers SOX2 or OCT4 in the adult pancreas (Zhao et 
al. 2007). However, CD34+ hESCs transplanted into sheep were able to provide higher 
levels of circulating human c-peptide than populations with heterogeneous cell 
expression (Goodrich et al. 2010), demonstrating that CD34+ hESCs have the potential to 
give rise to insulin-producing cell-like fate.  
1.6.3 CD117 
CD117 is a receptor tyrosine kinase found in progenitor cells from multiple sources, 
including bone marrow-derived hematopoietic cells (Wodja et al. 2003), bone marrow 
cells (Hess et al. 2003), and in tumour cell populations (Pietsch et al. 1998). Furthermore, 
CD117 is associated with endoderm cell commitment in precursor hESCs (Cheng et al. 
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2012). The ligand of CD117 is stem cell factor (SCF), and SCF plays an important role 
for increasing endocrine expression in the human fetal pancreas (Li et al. 2006). In the rat 
pancreas, CD117 has been isolated in cells close to the ducts and within the islets 
(Joanette et al. 2004, Wang et al. 2004). Further examination of the islet populations 
showed that rat epithelial monolayers expanded from isolated islets on collagen I gels, 
contained an increased number of proliferating CD117-expressing cells with constant 
expression of Pdx-1, Ngn3, Pax4, and multiple undifferentiated cell markers, including 
Oct4 and α-fetoprotein (Wang et al. 2004). Islet-like clusters with increased insulin+ and 
glucagon+ cells were formed from the monolayer when cultured on laminin-rich matrigel, 
and the cells secreted insulin in response to glucose (Wang et al. 2004). In a pancreatic 
duct ligation model, the ligated portion showed an increase of CD117+ cells in ductal and 
islet cells with increased Pdx-1 and CD117 co-localization (Peters et al. 2005), indicating 
possible pancreatic regeneration from a progenitor cell source. In the human fetal 
pancreas, CD117 expression in the ductal cells decreased with age, but co-localized with 
insulin+ and glucagon+ cells and remained consistent in islet cells (Li et al. 2007). Similar 
to human pancreata, the expression of CD117 drops in the islets, acinar, and ductal cells 
of postnatal rats after birth, with the majority of CD117 cells surrounding the islet 
(Yashpal et al. 2004). Murine pancreata during later stages of embryonic development 
showed high co-localization of CD117 with Ngn3 and insulin (Ma et al. 2012). In parallel 
to murine development, exogenous activation of CD117 in the human fetal pancreas 
leads to increased PDX-1 and insulin protein expression (Li et al. 2007). Further 
examination of CD117 revealed that reduction of CD117 in PANC-1 cells (a human 
pancreatic epithelial cancer cell line) led to decreased PDX-1 and insulin expression (Wu 
et al. 2010). Similar to CD34, mesenchymal cells isolated from human placenta express 
CD117; these cells were able to differentiate into islet-like clusters in vivo and 
demonstrated successful insulin production (Kadam et al. 2010). The transplantation of 
murine bone marrow-isolated CD117+ cells into STZ mice reduced circulating blood 
glucose, and even outperformed larger cell transplantation populations of CD117- cells 
(Hess et al. 2003). Overall, previous works examining CD117 suggest that it is an 
important marker for β-cell differentiation and regeneration.   
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1.6.4 Additional surface stem cell markers 
Alongside the surface markers listed above, additional cell surface markers have recently 
been studied and identified as indicators for pancreatic cell fate. CD24 cells highly co-
express PDX-1 in definitive endoderm hESCs, and have the capacity to differentiate into 
insulin-producing cells compared to cells that do not express this surface marker (Jiang et 
al. 2011). It is important to note that the exclusivity of the CD24 marker to PDX-1 cells 
has been challenged in repeated hESC experiments, where CD24 was also present on 
cells that did not stain for PDX-1 (Naujok and Lenzen. 2012). Stage-specific embryonic 
antigen 4 (SSEA4) is another novel progenitor marker that can be found in cells 
surrounding the endocrine cells of the pancreas (Afrikanova et al. 2012). It co-localizes 
with CD133 in the adult human pancreas and NGN3 in the fetal human pancreas 
(Afrikanova et al. 2012). c-Met, like CD117, is another receptor tyrosine kinase (Bladt et 
al. 1995) that is found in small percentages on the acinar and ductal cells of the 
developing murine pancreas (Suzuki et al. 2004). 
1.7 Aldehyde Dehydrogenase 
Although cell surface markers are frequently used to identify stem cells, intracellular 
markers have also been examined. Aldehyde dehydrogenase (ALDH) is an NAD+ 
dependent enzyme (Hammen et al. 2002) found in the cytosol and mitochondria of cells 
in many different vertebrae (Jackson et al. 2011). It has been detected in various tissue 
types, including the endoderm-derived liver (Kiefer et al. 2012), lung (Hind et al. 2002), 
and stomach (Yin et al. 1988). ALDH is also currently regarded as a useful marker for 
identifying stem cells in normal and malignant tissue populations. As a result, recent 
research regarding ALDH has focused on its potential as a stem cell marker. 
1.7.1 The ALDH family and Retinoic Acid 
The 19 isoforms of ALDH are grouped within the families ALDH1 (1A1, 1A2, 1A3, 
1B1, 1L1, 1L2), ALDH2, ALDH3 (3A1, 3A2, 3B1, 3B2), ALDH4 (4A1), ALDH5 
(5A1), ALDH6 (6A1), ALDH7 (7A1), ALDH8 (8A1), ALDH9 (9A1), ALDH16 (16A1), 
and ALDH18 (18A1) (Jackson et al. 2011). Cytosolic ALDH isoforms found within the 
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ALDH1 class are responsible for retinoic acid conversion from retinaldehyde (Marchitti 
et al. 2008), and are subsequently known as the retinaldehyde dehydrogenase (RALDH) 
class (Niederreither et al. 2002) (Figure 1.3). They can affect the production of retinoic 
acid in the developing system, as seen in mice with ALDH1a1 deletions and stunted 
retinoic acid conversion (Molotkov and Duester. 2003).  
Retinoic acid (RA), the product of the retinaldehyde dehydrogenase class, can induce 
differentiation towards specific cell fate (Andrews. 1984, Wobus et al. 1997, Cai et al. 
2010), and can induce multipotent stem cells towards pancreatic cell fate (Micallef et al. 
2005). Retinoic acid regulates two different types of receptors, the retinoic acid receptors 
(RAR) and the retinoid X receptors (RXR). Retinoic acid stimulates RAR-RXR dimer 
formation and binding of the dimer to DNA (Rastinejad et al. 2000), affecting the 
expression of retinoic acid response elements (Glass et al. 1991) and regulating gene 
transcription (Li et al. 2014). All-trans retinoic acid (ATRA) is one isoform of retinoic 
acid found to affect embryonic development (Klug et al. 1989). It binds to the RAR 
group, but has low affinity for RXR binding (Heyman et al. 1992). 9-cis retinoic acid (9-
cis RA) is another retinoic acid isomer similar to ATRA, but has the ability to bind to 
RAR and RXR sites (Heyman et al. 1992). Consistent treatment of ALDH1-expressing 
cells with ATRA and 9-cis RA demonstrated dose-dependent down-regulation of ALDH 
(Moreb et al. 2005), indicating that sufficient production of RA can lead to down-
regulation of its producing enzyme. Diethylaminobenzaldehyde (DEAB) is the major 
reversible inhibitor associated with halting ALDH activity (Russo et al. 1995) (Figure 
1.3), and its actions have been demonstrated across multiple isoforms of ALDH (Moreb 
et al. 2012).  
1.7.2 ALDH and its use as a stem cell marker 
Primary cells with ALDH activity display characteristics associated with stem cells, 
including the ability to promote self-renew via proliferative capacity and differentiation 
towards to other cell types (Ginestier et al. 2007, Burger et al. 2009). As such, ALDH   
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Figure 1.3 Retinoic acid in cell differentiation and proliferation. Inhibition of retinoic 
acid production with DEAB treatment prevents differentiation of cells, but is reversed 
with exogenous retinoic acid treatment. The dimerization of RAR-RXR regulates TF 
expression, and stimulates cell proliferation and differentiation. Modified from Li et al. 
(2014).  
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has extensively been examined in different tissues and in vitro stem cell sources to further 
elucidate its role in multipotent cell fate (Corti et al. 2006). ALDH-expressing cells 
isolated from tissue demonstrated the ability to form replicating spheres in vitro, which 
retained the stem cell property of self-renewal (Ginestier et al. 2007, Lindgren et al. 2011, 
Li et al. 2010). In contrast, the inhibition of ALDH via DEAB has been linked to halting 
differentiation, illustrating the regulatory role of ALDH in multipotent populations. This 
was seen in hematopoietic stem cells that had been exposed to DEAB, where it resulted 
in an extension to their immature progenitor state (Muramoto et al. 2010). ATRA 
treatment has been found to rescue DEAB-inhibited cell populations and lead to 
differentiation (Figure 1.3) (Chute et al. 2006, Muramoto et al. 2010, Li et al. 2014), 
suggesting that while ALDH can serve as an identifying factor of stem cells, it is 
important for driving cell differentiation via regulation of retinoic acid. The retinoic acid- 
producing isoform Aldh1a1 is highly expressed in murine hematopoietic stem cells, but 
its deficiency in mice does not affect the function of this stem cell population (Levi et al. 
2009). This suggests that although ALDH is an important factor in stem cells, it is not the 
sole regulator of stem and progenitor cells.  
The relationship between ALDH and other markers of stem cell fate has also been 
demonstrated in different types of stem cells, aiding in the isolation of multipotent cells 
by using stem cell-associated markers to further characterize ALDH cell populations 
(Hess et al. 2004, Burger et al. 2009). Cells positive for the SSEA4 marker express higher 
levels of the ALDH1A1 isoform than SSEA4 negative cells in the developing human 
pancreas (Afrikanova et al. 2012), and in the adult murine pancreas, isolated ALDH+ 
cells that co-localize highly with the CD133 surface marker showed the ability to 
differentiate into multiple pancreatic cell types (Rovira et al. 2010). This establishes that 
by pairing the expression of stem cell markers with high ALDH activity in tissue, it may 
be possible to precisely isolate cells that display regenerative capabilities. However, 
previous research has shown variations, with hematopoietic stem cell studies 
demonstrating the presence (Storms et al. 2005) and absence (Armstrong et al. 2004) of 
the CD34 marker on ALDH+ populations, emphasizing the complexity of using ALDH 
co-localization studies for stem cell identification.   
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Although the presence of ALDH can indicate a normal stem cell population, stem cells 
found in cancerous tissue also express ALDH and have subsequently led to multiple 
papers examining this enzyme. It is important to note that ALDH does not serve as a 
guaranteed marker for cancerous cells; cells with low ALDH expression have also 
demonstrated neoplastic properties in vivo (Prasmickaite et al. 2010), agreeing with 
developmental studies that show multiple markers that indicate stem cell multipotency. 
ALDH1 is high in cancers affecting many endoderm-derived tissues, including the 
pancreas, and has been linked to poor patient survival rates (Deng et al. 2010). In addition 
to this, the activity of ALDH in tumour tissue has been linked to chemotherapy drug 
resistance (Croker and Allan. 2012). 
1.8 The Role of ALDH and RA in Pancreatic Development 
and Function 
Current research examining pancreatic development has found that ALDH and its 
associated receptors can alter the cell composition of an organ. The ALDH1A1 isoform 
has been identified as the form that makes up a large majority of ALDHhi pancreatic cells 
in both fetal (Li et al. 2014) and adult human pancreata (Chiang et al. 2009). Both RAR 
and RXR have been detected in the pancreas during embryonic murine formation, with 
isoform expression varying in different regions of the pancreas (Kadison et al. 2001, 
Kobayashi et al. 2002), indicating that there is ATRA and 9-cisRA activity during 
development (Kane et al. 2010). A summary can be found in Figure 1.4. 
1.8.1 Endocrine Fate and the Formation of Islet Cells 
The ALDH1 family affects endocrine cells within the developing pancreas. Analysis of 
ALDH1 activity in the developing human fetal pancreas was extensively examined in our 
laboratory (Li et al. 2014), and the findings will be covered in brief below. Although 
overall ALDH activity decreased in the developing human pancreas late in the 2nd 
trimester of pregnancy, the retinaldehyde dehydrogenase isoform ALDH1A1 level 
increased as pancreas development progressed (Li et al. 2014), indicating an important 
developmental role for retinoic acid during late development. Along with these findings,   
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Figure 1.4 Generation of pancreatic cell lineages with retinoic acid treatment. 
Differentiation studies reveal that the application of retinoic acid promotes the 
proliferation of specific pancreatic cell lineages while repressing others. Summarized 
from the references in Section 1.8.  
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ALDH1 cells highly co-localized (~90%) with SOX9, PDX-1, and NGN3 (Li et al. 
2014), and transcription factors downstream of NGN3 (NKX6.1, NKX2.2, and PAX6). 
Furthermore, isolated islet-epithelial clusters treated with ATRA led to significantly 
increased NGN3 and insulin in these clusters, indicating that endocrine as well as β-cell 
commitment is regulated by retinoic acid (Li et al. 2014). In tandem with the ATRA 
treatment, this study found that both the reduction of ALDH1A1 expression and 
inhibition of ALDH1A1 activity led to a reduction of insulin+ cells in these islet clusters 
(Li et al. 2014). In summary, the results from this study established the necessary role of 
ALDH1 and retinoic acid in the development of endocrine cells throughout pancreatic 
development.  
Additional studies have also focused on the contributions of ALDH and retinoic acid 
activity towards endocrine cell commitment by examining in vivo activity. Examination 
of the developing human pancreas found similar results seen in Li et al. (2014), where 
ALDH1A1 gene expression occurred parallel to detected Insulin expression and was 
particularly high during later developmental stages (Ostrom et al. 2008). Furthermore, 
insulin+ cell development from the endoderm is controlled by retinoic acid in zebrafish 
models (Stafford et al. 2006), suggesting that the role of retinoic acid in endocrine cell 
development is conserved throughout animal models. The mesenchymal cells of the 
pancreas are necessary for establishing its architecture, and have also been shown to play 
a role in promoting transcription factors needed for endocrine cell fate (Landsman et al. 
2011). Examination of the developing murine pancreas shows high levels of Aldh1a2 in 
dorsal bud mesenchymal cells that subsequently affects Pdx-1 expression and endocrine 
cell formation, revealing that retinoic acid production from other cell types in the 
pancreas can affect islet development (Tulachan et al. 2003, Martin et al. 2005).  
Embryonic stem cell studies conducted using hESCs have provided an important in vitro 
source for the examination of pancreatic fate commitment and subsequent islet 
development. Retinoic acid treatment of ESCs has repeatedly resulted in endoderm 
differentiation and expression of PDX-1 (Micallef et al 2005, Shim et al. 2007, 
Serafimidis et al. 2008, Johannesson et al. 2009, Nostro et al. 2011), and the continued 
differentiation of retinoic acid-treated hESCs can lead to the production of cells positive 
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for Insulin as well as inhibition of hepatic precursors from the definitive endoderm 
population (Cai et al. 2010), supporting the results seen during in vivo research. 
1.8.2 Exocrine Fate 
The exocrine portion of the pancreas is responsible for the release of digestive enzymes 
into the duodenum and arises from cells of the duodenum that retain expression of the 
pancreatic transcription factor Ptf1a (Kawaguchi et al. 2002). Current information on 
ALDH activity in regard to exocrine tissue development is limited, but studies have been 
conducted on the effects of retinoic acid on exocrine tissue. Treatment of murine 
embryonic pancreata with 9-cis RA reduces the percentage of amylase-expressing cells 
(Kobayashi et al. 2002), and similar results were seen when using ATRA on murine 
embryonic pancreata of a similar age (Shen et al. 2007). These results show that retinoic 
acid production in the pancreas largely inhibits the development of the acinar tissue, and 
suggests that ALDH activity is antagonistic of exocrine development. However, an 
increase in amylase tissue has been reported in developing murine pancreata treated with 
ATRA (Kadison et al. 2001), indicating that the role of retinoic acid in acinar 
development may be more complex than what is reported.  
Ductal structures within the pancreas are closely tied to the exocrine portion due to their 
role of transporting digestive enzymes secreted from acinar cells, but are also associated 
with giving rise to islet precursors during pancreatic development (Bouwens et al. 1997). 
ALDH expression has been observed in adult murine ductal cells that make close contact 
with acini (Rovira et al 2010) and is highly associated with ductal cells in the developing 
human fetal pancreas (Li et al. 2014), suggesting a possible progenitor pool in ductal 
cells. Although the presence of ALDH has been demonstrated in ductal cells, there is also 
reported information regarding the effects of retinoic acid on ductal cell development. 9-
cis RA gives rise to increased ductal cells in murine embryonic pancreata (Kadison et al. 
2001). Further analysis demonstrated that mesenchymal tissue is needed for 9-cis RA-
induced ductal formations in the pancreas, due to the expression of RARs in this tissue 
type (Kadison et al. 2001, Kobayashi et al. 2002). However, there are conflicting results 
regarding the use of ATRA to promote ductal differentiation in murine embryonic 
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pancreata, with results showing promotion (Tulachan et al. 2003) and suppression (Shen 
et al. 2007) of ductal cell development. Overall, current available research examining 
retinoic acid treatment (notably 9-cis RA) indicates that it stimulates ductal cell 
formation.  
Pancreatic stellate cells (PSCs) are characterized to be in either an unactivated quiescent 
stage or an activated stage that can produce extracellular matrices for repair (Apte et al. 
2012). PSC quiescence is stimulated with retinoic acid treatment (Froeling et al. 2011), 
and proliferation of stellate cells and production of the extracellular component collagen 
from these cells are inhibited with ATRA and 9-cis RA treatments, implying that ALDH 
activity restricts the activated cell type (Jaster et al. 2003, McCarroll et al 2006). 
1.9 Rationale, Objective, and Hypothesis 
Although ALDH activity has been extensively studied in neoplastic stem cells and in 
stem cells from other sources (ex: hematopoietic stem cells), limited research has been 
conducted on ALDH and its role in β-cell differentiation during human fetal pancreas 
development. Our lab recently looked at ALDH co-localization with TF- and hormone-
expressing cells in the whole human fetal pancreas during early 1st trimester (10 to 11 
weeks of fetal age) and late 2nd trimester (20 to 21weeks of fetal age) of pregnancy. The 
results demonstrated high co-localization of endocrine cell TFs and hormones with 
ALDH+ cells during development, leading to the conclusion that ALDH+ cells are 
important for endocrine cells throughout early and late human pancreatic development 
(Li et al. 2014). However, this previous study did not examine prospective sorted ALDH 
populations of the human fetal pancreas and characterize their markers and TFs in vitro 
and in vivo. Therefore, this project set out to separate ALDH populations from the 
developing human pancreas and assess their abilities to produce β-cells in vitro and in 
vivo. This thesis examined high (ALDHhi) or low (ALDHlo) ALDH populations in the 
developing human pancreas at 18 to 22 weeks of fetal age, and characterized the 
expression of putative stem cell markers and TFs in the sorted cells. Culture allowed for 
in vitro analysis of TF expression during expansion, while transplantation of sorted cells 
provided in vivo analysis of differentiation and maturation.   
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Objective 
To characterize the transcription factors (TFs) and putative stem cell markers in purified 
cell populations with high ALDH activity (ALDHhi) or low ALDH activity (ALDHlo) 
sorted cell populations in the developing human fetal pancreas, and to examine their 
phenotype in vitro and in vivo.  
 
Hypotheses 
1. ALDHhi cells denote a progenitor pool in the developing human pancreas. 
2.  ALDHhi cells express factors indicative of commitment to the endocrine cell fate, and 
can give rise to endocrine cell populations in vitro and in vivo.  
 
Specific Questions 
1. Do CD133, CD34, or CD117 co-localize exclusively with the ALDHhi populations in 
dissociated human fetal pancreatic cells? 
2. Does the ALDHhi sorted population contain TFs necessary for endocrine cell 
development? 
3. Could ALDHhi cells maintain their phenotypes during culture in vitro? 
4. Could cultured ALDHhi cells give rise to islet-like cell clusters? 
5. Does the subcutaneous transplantation of ALDHhi sorted cells, wrapped in fibrin gel, 
enhance differentiation towards the endocrine cell type in nude mice? 
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Chapter 2 – Materials and Methods 
2.1     Fluorescence-activated cell sorting 
2.1.1   Pancreas Tissue Dissociation 
Human fetal pancreata (18 to 22 weeks of fetal age) were obtained based on the approved 
protocol from the Health Human Sciences Research Ethics Board at Western University 
(Appendix A), in accordance with the Canadian Council on Health Sciences Research 
Involving Human Subjects guidelines. Fetal age is assigned two weeks later than the 
gestational age (based on the menstrual cycle), to account for the two weeks of pre-
ovulation that precede conception. Pancreata were carefully dissected by removing all 
surrounding non-pancreatic tissue, and then digested with a dissociation buffer (1x 
Hank’s Balanced Salt Solution (HBSS) [Sigma, Oakville, ON, Canada]; 25 mM HEPES 
[Sigma]; DNase I [Roche, Mississauga, ON, Canada]) containing collagenase V (1 
mg/ml) (Sigma) in a water bath at 37°C for 30 minutes (Al-Masri et al. 2010). To inhibit 
the active enzyme, dissociated samples were washed three times with cold wash buffer 
(1x HBSS (Sigma); NaHCO3; Soybean Trypsin Inhibitor (STI); Bovine Serum Albumin 
(BSA); Pen/Strep; Fungizone). To prepare pancreatic single cell suspensions, the samples 
were further treated with 0.25x Trypsin-EDTA (Mediatech Inc., Manassas, VA) and 
incubated again at 37°C for 5 minutes. Confirmation of single cells was achieved by 
examining the sample using an inverted light microscope (Leica DM IL; Leica 
Microsystems, Bannockburn, IL, U.S.A.). Due to time constraints, cells were kept at 4°C 
overnight in CMRL-1066 media (Mediatech Inc., Manassas, VA) with 10% fetal bovine 
serum (FBS) (Life Technologies Inc., Burlington, ON, CA) for cell sorting the following 
day at the London Regional Flow Cytometry Facility, Robarts Research Institute.  
2.1.2   Aldefluor and fluorophore-conjugated antibody staining 
Pancreatic single cells were centrifuged to remove CMRL-1066 media and then 
suspended in Aldefluor buffer (Stem Cell Technologies Inc., Vancouver, BC, CA). Cell 
viability was examined using 0.2% trypan blue (Gibco, Life Technologies) staining with 
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the automated Cellometer T4 cell counter (Nexcelom Bioscience, Lawrence, MA, 
U.S.A.). Viability ranged between 80% to 90% and the total number of live cells was 
between 6 x106 and 1 x107 cells per pancreatic single cell preparation. Fluorophore 
Minus One (FMO) control tubes were set up as negative controls for all fluorophores 
used, and were prepared with approximately 100,000 viable cells from the bulk 
population. Aldefluor reagent (StemCell Technologies) was applied to detect the 
intracellular activity of ALDH. The cell population was incubated at 37°C for 30 minutes 
in order for ALDH to convert the fluorescent BODIPY-aminoacetaldehyde (BAAA) in 
the Aldefluor reagent to BODIPY-aminoacetate (BAA), a negatively charged anion 
trapped within the cell (Storms et al. 1999, Balicki. 2007). The Aldefluor FMO control 
tube was treated with DEAB to inhibit ALDH activity and BAAA conversion. 
Fluorophore- conjugated antibodies listed in Table 2.1 were also used to examine surface 
stem cell marker populations (Hess et al. 2004). CD235a antibodies were used to remove 
erythrocytes from the sorted populations and prevent inaccurate cell population 
representation. Cells were incubated at 4°C for 30 minutes after antibody application. 
The viability marker 7-AAD (BD BioSciences, Mississauga, ON, CA) was added to each 
tube before sorting the cells in order to mark live versus dead cells within the final 
populations. Cells were stored on ice to retain Aldefluor fluorescence until the time of 
sort.  
2.1.3   Fluorescence-activated cell sorting procedure 
Prepared cells were sorted using the FACSAria III Cell Sorter (BD Biosciences, San 
Jose, CA, U.S.A.), and analyzed using FACSDiva software (BD Biosciences). FMO 
control tubes were used to properly gate the cell populations marked with each 
fluorophore. The sample tube was sorted into two of the following populations: 1) 
ALDHhi and ALDHlo populations; or 2) cell surface markerhi/ALDHhi or ALDHlo, and 
cell surface markerlo/ALDHhi or ALDHlo populations.  
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Table 2.1: List of antibodies used for fluorescence-activated cell sorting 
Antibody Dilution Company 
Mouse anti-human CD34 BV-
conjugated 
2 µl/ 1 x107 
 
BioLegend Inc., San Diego, CA, US 
Mouse anti- human CD117 PE-
conjugated 
2 µl/ 1 x107 BioLegend Inc., San Diego, CA, US 
Mouse anti-human CD133 APC-
conjugated 
4 µl/ 1 x107 Miltenyi Biotec Inc., Auburn, CA, US  
Mouse anti-human CD133 PE-
conjugated 
2 µl/ 1 x107 Miltenyi Biotec Inc., Auburn, CA, US 
Mouse anti-human CD235a PerCP-
Vio700-conjugated 
8 µl/ 1 x107 Miltenyi Biotec Inc., Auburn, CA, US 
Mouse anti-human CD235ab APC-
conjugated 
2 µl/ 1 x107 BioLegend Inc., San Diego, CA, US 
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2.2     Histological Analysis of Cell Populations 
2.2.1   Paraffin Block Preparation of Sorted Cell Samples 
Sorted cells were washed in PBS and fixed in 4% paraformaldehyde (PFA) (Fischer 
Scientific Company, Ottawa, ON, Canada) at 4°C overnight. The cell pellet was 
embedded in 2% agarose gel and then placed in cassettes for paraffin embedding as 
previously described (Lyttle et al. 2008). The processing procedure involved the 
following steps using an automated tissue processing machine (Shandon Citadel™ Tissue 
Processor, Thermo Electron Corporation; Waltham, Massachusetts, USA): 1) dehydration 
baths with increasing ethanol concentration (70% to 100%); 2) toluene baths; and 3) 
paraffin wax baths. The processed samples were embedded in paraffin-filled molds and 
fixed on a cold plate using an embedding machine (Thermo Shandon Histocentre 2, 
Thermo Scientific, Pittsburg, PA, U.S.A) to make paraffin blocks.  
2.2.2   Immunofluorescence Staining 
Paraffin blocks were sectioned using a microtome (Leica RM2245, Leica Biosystems) at 
4µm, and set aside to warm overnight. Removal of all paraffin from slides was done in 
xylene baths, and cells were rehydrated in baths of decreasing ethanol concentration 
(from 100% to 70%). For the staining of transcription factors, slides were pretreated in 
either a citrate antigen retrieval solution (pH 6.0) or a trypsin-EDTA antigen retrieval 
solution (pH 8.9) for heat-induced antigen retrieval of fixed epitopes (Cattoretti et al. 
1993). Blocking solution with 10% goat serum was applied in order to block the non-
specific adhesion of antibodies. A list of primary antibodies used in this study is shown in 
Table 2.2, and slides were incubated overnight at 4°C after primary antibody application. 
Fluorescein isothiocyanate (FITC) and tetramethyl rhodamine isothiocyanate (TRITC)-
conjugated secondary antibodies (JRL; West Grove, PA, U.S.A.) reactive to the primary 
antibody species were diluted (1:50 dilution) and incubated at room temperature for 1 
hour. Cell nuclei were counter-stained by 4’,6-diamidino-2-phenylindole (DAPI) (10 
mg/mL) (Sigma), and the slides were mounted with a cover slip using mounting medium 
(Dako, Burlington, ON, CA). Fluorescent staining signals were examined using a 
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fluorescent microscope (Leica DMIRE2; Leica Microsystems) and analyzed using the 
Image ProPlus software (Media Cybernetics Inc., Rockville, MD, U.S.A.). The cell 
counter program in the Image ProPlus software (Media Cybernetics Inc.) was used to 
quantify the total number of cells positive for the examined antigen, and this was 
normalized to the total number of cells per section and expressed as percentage. 
Secondary antibody was excluded from staining for negative controls. 
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Table 2.2: List of primary antibodies used for immunofluorescence staining 
Primary Antibody Dilution Company 
Mouse anti-ALDH 1:100 BD Biosciences, Mississauga, ON, CA 
Rabbit anti-CD31 1:50 Santa Cruz Biotechnology Inc., CA, US 
Rabbit anti-CD34 1:50 Santa Cruz Biotechnology Inc., CA, US 
Rabbit anti-CD117 1:50 Santa Cruz Biotechnology Inc., CA, US 
Rabbit anti-CD133 1:100 Biorbyt Ltd., Cambridge, U.K. 
Rabbit anti-CK19 1:100 Abcam Inc., MA, USA 
Mouse anti-CK19 1:50 Dako Canada Inc., Burlington, ON, CA 
Rabbit anti-E-cadherin 1:50 Abcam Inc., MA, USA 
Mouse anti-Glucagon 1:800 Sigma-Aldrich, Oakville ON, CA 
Rabbit anti-Glucagon 1:50 Santa Cruz Biotechnology Inc., CA, US 
Mouse anti-HMS 1:100 Millipore Canada Ltd., Etobicoke, ON, CA 
Mouse anti-Insulin 1:800 Sigma-Aldrich, Oakville ON, CA 
Rabbit anti-Insulin 1:50 Santa Cruz Biotechnology Inc., CA, US 
Mouse anti-ISL1 1:100 DSHB, Iowa City, IA, US 
Mouse anti-Ki67 1:100 BD Biosciences, Mississauga, ON, CA 
Mouse anti-NGN3 1:100 DSHB, Iowa City, IA, US 
Mouse anti-NKX2.2 1:100 DSHB, Iowa City, IA, US 
Mouse anti-NKX6.1 1:100 DSHB, Iowa City, IA, US 
Rabbit anti-PAX6 1:50 Santa Cruz Biotechnology Inc., CA, US 
Guinea Pig anti-PDX-1 1:800 Dr. Wright, University of Vanderbilt, US 
Rabbit anti-PDX-1 1:800 Dr. Wright, University of Vanderbilt, US 
Mouse anti-SOX9 1:100 Abcam Inc., MA, USA 
Rabbit anti-SOX9 1:50 Santa Cruz Biotechnology Inc., CA, US 
Mouse anti-Vimentin 1:100 DSHB, Iowa City, IA, US 
Rabbit anti-β-catenin 1:500 Millipore Canada Ltd., Etobicoke, ON, CA 
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2.3     Quantitative Real-time Reverse Transcriptase 
Polymerase Chain Reaction (qRT-PCR) 
2.3.1   RNA Isolation 
ALDHhi and ALDHlo cells gathered immediately after sort and expanded culture were 
washed with sterile PBS. The cell pellets were lysed in cell lysis buffer using the 
RNAqueous-4PCR kit (Life Technologies) according to the manufacturer’s instructions. 
In brief, the cell lysate was vortexed intermittently to break up cells and then treated with 
64% ethanol. RNA was collected using a collection filter and washed with wash buffer 
(Life Technologies), and heated elution solution (Life Technologies) was used to collect 
the RNA from the filter. DNAse buffer (Life Technologies) and DNAse (Life 
Technologies) were added to the elution solution sample to eliminate DNA 
contamination, and samples were incubated at 37°C for 30 minutes. The isolated RNA 
solution was stored at -80°C prior to reverse transcription. RNA concentrations were 
measured using 250 µL of DEPC H2O and 1 µL of RNA sample, then analyzed using a 
Multiskan Spectrometer (Thermo Scientific). RNA samples with a concentration higher 
than 0.1µg/µL were used for reverse transcription. The quality of the RNA was checked 
by running samples on a 1% agarose gel with ethidium bromide, and confirmed with the 
visual observation of 28S and 18S bands.  
2.3.2   Reverse Transcription and cDNA Synthesis 
RNA samples were heated with the addition of random hexamers (3000 ng/mL), Oligo 
dT, and DEPC H2O at 60°C for 5 minutes and 4°C for 5 minutes using the GeneAmp 
PCR System 2400 (Applied Biosystems Inc., Foster City, CA, U.S.A.). The master mix 
(4 µL of 5x buffer, 2 µL of DTT, 2 µL of 10 mM dNTPs, and 0.5 µL RNAsin) was added 
to each RNA sample and then centrifuged for 30 seconds. The samples were then heated 
on the GeneAmp PCR System (Applied Biosystems) at the following temperatures: 42°C 
for 90 minutes, 94°C for 5 minutes, and 4°C for 60 minutes. SuperScript® II Reverse 
Transcriptase (Invitrogen, Burlington, ON, Canada) was added to each sample while in 
the PCR System at 42°C. A final concentration of 6 µg/ 80 µL for each sample was 
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achieved by diluting with sterile H2O. The cDNA samples were then stored at -20°C prior 
to qRT-PCR reactions. Negative control samples were generated by excluding RNA 
during the reaction. 
2.3.3   qRT-PCR Measurements 
Each well for the real-time reaction was prepared using the following: 3 µL of sterile 
H2O, 0.5 µL forward primer, 0.5 µL reverse primer, 1 µL cDNA sample, and 5 µL SYBR 
Green Master mix. The list of primers used and the annealing temperatures are listed in 
Table 2.3. Negative template controls were used to verify primer specific amplification, 
and prepared by substituting the primer volume with sterile H2O. After adding the 
appropriate volumes, the reaction wells were mixed and loaded on to the Bio-Rad CFX 
Connect™ real-time PCR detection system (Bio-Rad Laboratories Canada Ltd., 
Mississauga, ON, CA) and analyzed using the CFX Manager software (Bio-Rad). The 
melting curves were used to indicate if the qRT-PCR assays had amplified target 
sequences, and relative gene expression was analyzed using the comparative CT method 
(2-ΔΔCT) (Schmittgen et al. 2008) and the housekeeping gene 18S. 
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Table 2.3: List of primer sequences used in qRT-PCR analysis 
Primer 
Accession  
Definition 
Sequence 5’- 3’ 
(Sense/Antisense) 
Fragment 
Size (bp) 
Annealing 
Temperature 
(oC) 
INSULIN NM_000207.2 
 
TCA CAC CTG GTG GAA GCT CTC TA 
ACA ATG CCA CGC TTC TGC AGG GAC 
179 56.9 
NGN3 NM_020999.3 
 
AGC CGG CCT AAG AGC GAG TT 
TTG GTG AGC TTC GCG TCG TC 
 158 59.3 
NKX6.1 NM_006168.2 
 
AGA CCC ACT TTT TCC GGA CA 
CCG CTG CTG GAC TTG TGC TT 
 335 56.6 
PDX-1 NM_000209.3 
 
CTC CTA CAG CAC TCC ACC TTG 
CCG AGT AAG AAT GGC TTT ATG 
 153 56.0 
SOX9 
 
 
18S 
NM_000346.3 
 
 
NR_003286.2 
 
ACA AGA AGG ACC ACC CGG ATT A 
AGC TCG CCG ATG TCC ACG TCG C 
 
GTA ACC CGT TGA ACC CCA TTC 
CCA TCC AAT CGG TAG TAG CG 
 
 340 
 
 
 151 
57.2 
 
 
55.8 
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2.4     Cell Culture Experiments 
2.4.1   Examination of Extracellular Matrices on Sorted Cells  
In order to examine which extracellular matrix preparation best promoted the viability of 
ALDHhi cells, a modified protocol used in Krishnamurthy et al. (2008) was implemented. 
Tissue culture plates (96 well, Falcon BD Beckson Dickson) were coated with 5 µg/mL 
of the following matrices at room temperature for 1 hour: control (1% BSA solution), 
Fibronectin, Laminin, Collagen I, and Collagen IV (BD Biosciences). ALDHhi cells were 
plated on top of wells coated with matrices at a density of 1 x104 cells/ well in 100 µL of 
DMEM/ F12 + 10% FBS (Life Technologies) media. Cell viability was measured at 24 
hours and 5 days by treating the well with 100 µL of fresh DMEM/ F12+ 10% FBS 
media and 10 µL of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide 
(MTT, Sigma) reagent (5 mg/mL), then incubating the samples for two hours at 37°C in 
the tissue culture incubator. The MTT positive viable cells (per well) were imaged using 
an inverted light microscope (Leica DM IL; Leica Microsystems) and analyzed with 
Image ProPlus software (Media Cybernetics Inc). Quantification of the number of viable 
cells was conducted by selecting five consistent fields in each well, and counting the 
number of MTT positive cells normalized to the total number of adhered cells per 
experimental group. Data were expressed as a percentage of viable cells with 3 
experimental replications/group treatment.  
2.4.2   Expansion Culture of ALDHhi and ALDHlo Cells 
Based on the optimal viable cell results from ECM culture tests, the expansion culture 
was performed on the collagen I matrix coated culture plate. Sorted ALDHhi and ALDHlo 
cells were expanded on collagen I coated 12-well tissue culture plates with 1 mL DMEM/ 
F12 + 10% FBS (Life Technologies). Media was changed every 48 hours and cells were 
passaged once wells were 90 to 95% confluent. To examine expanded cell phenotype, 
cells were harvested for RNA extraction and histological analysis during expansion at 
different passages.  
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2.4.3   Differentiation Culture of ALDHhi and ALDHlo Cells 
Passaged cells from ALDHhi and ALDHlo sorted cell expansion were plated in 12-well 
plates and cultured with 1mL of serum-free differentiation media (Gershengorn et al. 
2004, Wu et al. 2010) in order to examine whether these cells could differentiate into 
endocrine cells. The cell cluster formation was monitored at 0 hours, 36 hours, and 7 days 
using an inverted light microscope (Leica DM IL; Leica Microsystems). Clusters were 
then collected for RNA extraction and histological analysis at day 7 of the culture.  
2.5     Transplantation of Sorted Cells in Nude Mice 
The transplantation of sorted cells was conducted to examine the effects that an in vivo 
environment had on the differentiation of ALDHhi sorted populations to endocrine 
lineage. Immediately after cell sorting, ALDHhi and ALDHlo cells were embedded in 100 
µL of fibrin in a 96-well plate to form a 3D gel (Riopel et al. 2013) and cultured with 100 
µL of Epicult-C plus 10% FBS media (StemCell Technologies, BC, Canada). After 24 
hours of culture, ALDHhi or ALDHlo cells in fibrin gels were fixed in 4% PFA, 
embedded in 2% agarose gel, and processed in paraffin blocks for histological analysis. 
Additionally, ALDHhi or ALDHlo cells cultured overnight in fibrin gels were 
subcutaneously transplanted to nude mice, and an empty fibrin gel served as a negative 
control group. In brief, 8 week-old male nude mice were anesthetized with isoflurane and 
either empty gels or gels containing 24 hours cultured ALDHhi or ALDHlo cells were 
implanted subcutaneously. Mice were sacrificed at 1 week post-transplantation, where 
grafts were harvested for histological analyses. Animal work was performed using 
protocols approved by the Animal Use Subcommittee at the University of Western 
Ontario in accordance with the guidelines of the Canadian Council of Animal Care 
(Appendix D). 
2.6     Statistical Analysis 
Data are expressed as mean ± SEM. Statistical analysis between ALDHhi and ALDHlo 
groups for all FACS and qRT-PCR experiments were done using a two-tailed paired 
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Student t-test using GraphPad Prism program (Version 5.0c, GraphPad Software Inc., La 
Jolla, CA, USA). Immunofluorescence analysis was performed using two-tailed unpaired 
Student t-tests to account for the use of unpaired sorted groups in these experiments. 
Statistical significance of analyzed data was achieved at p<0.05.  
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Chapter 3 -Results 
3.1 FACS analysis for ALDHhi and ALDHlo groups  
To isolate the ALDHhi cell population in the developing human fetal pancreas, 
fluorescence-activated cell sorting (FACS) analysis by the FACSAria III Cell Sorter (BD 
Bioscience) was performed. Before cell sorting, the cell viability and cell diameter was 
examined using the automated Cellometer T4 cell counter.  The bulk dissociated cells 
demonstrated high viability (82.42 ± 2.11%), determined by trypan blue staining, and 
consistent cell diameter size (9.0 ± 0.1 µm). The average total live cell population was 
approximately 8.27 x106 cells per dissociated human fetal pancreas. Viable dissociated 
human fetal pancreatic cells were first gated (isolation of populations of interest) using 
the fluorescent viability dye 7-aminoactinomycin D (7-AAD) (Figure 3.1A), and dead 
cells (7-AAD+) were discarded during cell sorting. Erythrocyte removal from the sorted 
cell tubes was completed by gating out cells that stained positive for the erythrocyte 
surface marker CD235a (Glycophorin A) (Figure 3.1B). Sorted cell populations were 
verified based on cell size (Forward Scatter Plot, FSC) and cell internal complexity (Side 
Scatter Plot, SSC) (Figures 3.1C). Separating Aldefluor-expressing cells from the viable 
bulk cell population was done by using the DEAB negative control to represent the 
ALDHlo population during Aldefluor fluorescence gating (Figure 3.1D, E). The purity of 
the ALDHhi (94.63 ± 0.60%) and ALDHlo (99.67 ± 0.15%) sorted populations was 
confirmed analyzing their Aldefluor expression. Viable cells after sorting largely 
belonged to the ALDHhi sorted population (65.87 ± 3.54%), compared to the ALDHlo 
population (28.37 ± 3.50%) (p<0.001; Figure 3.1F). 
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Figure 3.1 Isolation of viable cell populations using fluorescence-activated cell 
sorting   
(A) Removal of non-viable (7-AAD high) cells using gating during cell sorting. (B) 
Erythrocyte removal from the final sort population labeled by the cell surface marker 
CD235a antibody. (C) Single cell population based on cell size (Forward Scatter plot, 
FSC) and cell internal complexity (Side Scatter plot, SSC). (D) Separation of the sorted 
ALDHhi and ALDHlo pancreatic populations, using Aldefluor fluorescence gating to 
isolate ALDH activity. (E) ALDH inhibitor diethylaminobenzaldehyde (DEAB) was used 
as a negative control in conjunction with Aldefluor to set the population separation 
between ALDHhi and ALDHlo cells. (F) Quantification of ALDHhi and ALDHlo viability 
in the final sorted population. ALDHhi cells, green; ALDHlo cells, blue; non-viable and 
excluded cells, grey population. Data are expressed as mean ± SEM and were analyzed 
using paired t-tests (n=15 sorted pancreata/group). *** p<0.001 vs. ALDHlo sorted 
population. 
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3.2 Characterization of Stem Cell Surface Markers in Sorted 
ALDHhi and ALDHlo populations  
The putative stem cell surface markers CD133, CD34, and CD117 expression have 
previously been demonstrated on a variety of stem cell lineages. Therefore, these cell 
surface markers were analyzed during FACS to determine their co-localization 
frequencies in the sorted populations. CD133+ cells were present in both ALDHhi and 
ALDHlo sorted populations, yet CD133 had significantly higher expression in ALDHhi 
cells (65.82 ± 4.58%) when compared to ALDHlo sorted cells (8.15 ± 3.28%) (p<0.05, 
Figure 3.2A,D). In comparison, the CD34+ marker was significantly higher in the 
ALDHlo group (41.56 ± 2.78%) than the ALDHhi population (24.32 ± 2.86%) (p<0.05, 
Figure 3.2B,D). No significant difference was detected for CD117+ expression between 
the ALDHhi (12.64 ± 8.45%) and ALDHlo (10.56 ± 4.42%) populations (Figure 3.2C,D).  
To examine the ALDHhi and ALDHlo sorted cells for overlapping co-localization of 
surface stem cell markers, 3-colour multiparametric cell sorting analyses were performed. 
Overall, equivalent but low co-localization was seen in the ALDHhi and ALDHlo 
populations with CD117+/CD34+ surface markers (Figure 3.3A). Lower co-localization 
of CD133+/CD34+ surface markers (Figure 3.3B) and CD117+/CD133+ surface markers 
(Figure 3.3C) were also observed in both ALDHhi and ALDHlo sorted group. These 
results show that the CD133+ population in ALDHhi cells and CD34+ population in the 
ALDHlo cells do co-localize with other stem cell surface markers, but are largely 
independent of the chosen surface markers examined in this study. 
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Figure 3.2 Expression of surface stem cell markers within ALDHhi and ALDHlo 
populations using FACS.  
(A) Individual sorting plots for markers CD133, CD34, and CD117 (y-axis), and the co-
staining of Aldefluor (x-axis) for the detection of co-localizing populations. Boxed areas 
on scatter plots represent separated populations based on Aldefluor and fluorophore-
labeled antibody fluorescence intensity. (B) Quantification of the co-localized surface 
stem cell markers with ALDHhi and ALDHlo in sorted fetal pancreatic cells. White bar, 
ALDHhi group; black bar, ALDHlo group. Data are expressed as mean ± SEM and 
analyzed using paired t-tests (n=4-8 sorted pancreata/group). *** p<0.001 vs. ALDHlo 
sorted population. 
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Figure 3.3 Co-localization between surface stem cell markers in the ALDHhi and 
ALDHlo populations.  
Co-expression of sorted ALDHhi (left) and ALDHlo (right) populations, and quantitative 
analysis (far right) for CD117+/CD34+ (A), CD34+/CD133+ (B), and CD133+/CD117+ 
(C) in the sorted ALDHhi (left) and ALDHlo (middle) gated populations. Red lines 
indicate co-localization of stem cell surface markers with ALDH populations. White bar, 
ALDHhi group; black bar, ALDHlo group. Data are expressed as mean ± SEM and 
analyzed using paired t-tests (n=4 sorted pancreata/group) 
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3.3 Analysis of TFs in sorted ALDHhi and ALDHlo populations  
Commitment to endocrine, and specifically β-cell, fate in the pancreas requires a 
sequence of transcription factor activation. Initial transcription factors responsible for 
pancreatic progenitor fate (SOX9), pancreatic cell fate (PDX-1), and endocrine cell 
commitment (NGN3) precede factors associated with islet cells (ISL1, NKX2.2, 
NKX6.1, PAX6). Therefore, the analysis of transcription factor expression in ALDHhi 
sorted cells is necessary to determine the commitment of these cells towards the 
endocrine cell fate. qRT-PCR results, used to examine the mRNA expression of the 
transcription factors, demonstrated that there was relatively higher mRNA levels of 
SOX9, PDX-1, NGN3, and NKX6.1 expression in the ALDHhi cells, but statistical 
significance was not reached due to a high variability between the sample groups (Figure 
3.4). Using immunofluorescence staining to analyze the nuclear expression of these 
transcription factors, it was found that the SOX9+ cells had higher expression in the 
ALDHhi sorted cells compared to ALDHlo group (55 ± 3% vs. 14 ± 1%, p<0.001, Figure 
3.5). The PDX-1+ cells also had higher percentages in ALDHhi group the ALDHlo 
population (20 ± 2% vs. 2.0 ± 0.3%, p<0.001, Figure 3.5). This data, along with the 
surface stem cell marker results from the previous section, could indicate that the 
ALDHhi sorted population may represent a pancreatic precursor pool, but other cell fate 
possibilities must be examined before concluding this. The major transcription factor for 
endocrine cell fate is NGN3, and although there was increased NGN3+ labeling in the 
ALDHhi group (14 ± 5%) compared to ALDHlo group (3 ± 1%), there was no significant 
difference between the two cell populations (Figure 3.6). A similar pattern was observed 
in NKX2.2 staining where it was insignificantly higher in ALDHhi (4 ± 1%) sorted cells, 
compared to the ALDHlo (0.9 ± 0.2%) population (Figure 3.6). ISL1, an endocrine cell 
marker important for insulin secretion in β-cells (Ediger et al. 2014), did not make up a 
large population in the ALDHhi sorted group (3 ± 1%) but was significantly higher than 
the ALDHlo (0.6 ± 0.2%) sorted group (Figure 3.6). The transcription factors PAX6 (6 ± 
2% vs. 0.8 ± 0.3% in ALDHlo group, p<0.05) and NKX6.1 (12 ± 2% vs. 2 ± 1% in 
ALDHlo group, p<0.01) are present in the ALDHhi sorted cells (Figure 3.7). Taken 
together, higher percentages of endocrine transcription factors are expressed in the 
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ALDHhi sorted cells, suggesting that the ALDHhi population could represent an early 
progenitor population with low levels of endocrine specification.  
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Figure 3.4 qRT-PCR analysis of ALDHhi and ALDHlo sorted cells.  
mRNA expression of pancreatic transcription factors SOX9, PDX-1, NGN3, and NKX6.1 
was normalized to the housekeeping gene 18S and analyzed using the comparative Ct 
method (2- ΔΔCt). White bars, ALDHhi group; black bars, ALDHlo group. Data are 
expressed as mean ± SEM and analyzed using paired t-tests (n=4 sorted pancreata/group)  
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Figure 3.5 Pancreatic progenitor and pancreatic cell fate transcription factor 
analysis in the sorted populations.  
(A) Representative immunofluorescence images of SOX9 and PDX-1 (green) nuclei 
staining in the sorted ALDHhi and ALDHlo populations. DAPI (blue) was used for 
nuclear counter staining. White arrows indicate cells positive for TF. Scale bar: 15 µm. 
(B) Quantification of SOX9+ and PDX-1+ cells in the total sorted population. White bars, 
ALDHhi group; black bars, ALDHlo group. Data are expressed as mean ± SEM and 
analyzed using unpaired t-tests (n=3-5 sorted pancreata/group), *** p<0.001 vs. ALDHlo 
sorted population 
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Figure 3.6 Analysis of transcription factors for commitment to endocrine cell 
differentiation.  
(A) Representative images of NGN3, ISL1, and NKX2.2 (green) staining in the ALDHhi 
and ALDHlo sorted cell nuclei, labeled by DAPI (blue). White arrows indicate cells 
positive for TF. Scale bar: 15 µm. (B) Quantification of NGN3+, ISL+, and NKX2.2+ cells 
in the total sorted population. White bars, ALDHhi group; black bars, ALDHlo group. 
Data are expressed as mean ± SEM and analyzed using unpaired t-tests (n=2-4 sorted 
pancreata/group) * p<0.05 vs. ALDHlo sorted population. 
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Figure 3.7 Analysis of transcription factors associated with islet endocrine cells.  
(A) Representative images of NKX6.1 and PAX6 (green) staining in the ALDHhi and 
ALDHlo sorted cell nuclei, labeled by DAPI (blue). White arrows indicate cells positive 
for TF. Scale bar: 15 µm. (B) Quantification of NKX6.1+ and PAX6+ cells in the total 
sorted population. White bars, ALDHhi group; black bars, ALDHlo group. Data are 
expressed as mean ± SEM and analyzed using unpaired t-tests (n=3 sorted 
pancreata/group) * p<0.05, ** p<0.01 vs. ALDHlo sorted population. 
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3.4 Characterization of endocrine and ductal cells, and cell 
proliferation markers in sorted ALDHhi and ALDHlo 
populations  
Immunofluorescence staining was used in order to characterize the pancreatic cell 
composition of the sorted ALDHhi and ALDHlo groups, and to determine if one 
pancreatic cell type is favoured in the ALDHhi sorted group. Insulin was found to be the 
most common of the endocrine hormone markers, with significantly higher insulin+ cells 
in the ALDHhi population (5 ± 1%) and nearly undetectable levels in the ALDHlo 
population (0.8 ± 0.2%) (p<0.05; Figure 3.8). Somatostatin+ cells were also increased in 
the ALDHhi sorted cells (3 ± 0.5%), compared to the ALDHlo sorted cells (0.7 ± 0.4%) 
(p<0.05; Figure 3.8). However, there was no significant difference in glucagon+ cells 
between the sorted ALDHhi and ALDHlo groups (Figure 3.8). The epithelial cell markers, 
CK19 and E-cadherin, were expressed in relatively low levels in both the ALDHhi and 
ALDHlo populations (Figure 3.9). The expression of β-catenin, another epithelial-linked 
marker, was also examined and showed relatively similar expression levels in both 
ALDHhi and ALDHlo populations (Figure 3.10). Furthermore, the mesenchymal marker 
vimentin was present in the ALDHhi and ALDHlo populations, with a higher presence 
demonstrated in the ALDHlo group (Figure 3.10), indicating that the ALDHhi population 
is mostly devoid of mesenchymal cells. The active cell cycle marker Ki67 marks 
proliferating cells, and was used to examine the proliferation of the sorted cell 
populations. Interestingly, the ALDHlo population had a higher percentage of Ki67+ cells 
(17 ± 1%) at the time of sort compared to the ALDHhi population (10 ± 1%) (p<0.05; 
Figure 3.11). This data suggests that cells in the ALDHhi population are not active in the 
cell cycle at the time of sort, and that the proliferating portion of the sorted pancreata is 
largely found in the ALDHlo cells. 
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Figure 3.8 Analysis of islet-specific hormone expressing cells in the sorted 
populations. 
(A) Representative images for insulin (β-cell), glucagon (α-cell), and somatostatin (δ-
cell) (green) staining in the ALDHhi and ALDHlo sorted cell nuclei, labeled by DAPI 
(blue). White arrows indicate positive cell staining. Scale bar: 15 µm. (B) Quantitative 
analysis of hormone+ co-localization in the sorted population. White bars, ALDHhi group; 
black bars, ALDHlo group. Data are expressed as mean ± SEM and analyzed using 
unpaired t-tests (n=3-4 sorted pancreata/group) * p<0.05 vs. ALDHlo sorted population. 
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Figure 3.9 Characterization of sorted ALDHhi and ALDHlo populations for 
epithelial markers. 
(A) Representative images for CK19 and E-cadherin, markers of epithelial staining 
(green), stained against the total ALDHhi and ALDHlo sorted cell nuclei, labeled by DAPI 
(blue). White arrows indicate positive cell staining. Scale bar: 15 µm. (B) Quantification 
of CK19+ and E-cadherin+ cells in the sorted cell population. White bars, ALDHhi group; 
black bar, ALDHlo group. Data are expressed as mean ± SEM and analyzed using 
unpaired t-tests (n=2-3 sorted pancreata/group)  
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Figure 3.10 Characterization of sorted ALDHhi and ALDHlo populations for 
epithelial and mesenchymal markers. 
Representative images for epithelial marker β-catenin (A), and mesenchymal cell marker 
vimentin (B) (green), stained against the total ALDHhi and ALDHlo sorted cell nuclei, 
labeled by DAPI (blue). White arrows indicate positive cell staining. Scale bar: 15 µm. 
(C) Quantification of β-catenin+ and vimentin+ cells in the sorted cell population. White 
bars, ALDHhi group; black bar, ALDHlo group. Data are expressed as mean ± SEM and 
analyzed using unpaired t-tests (n=2-3 sorted pancreata/group)  
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Figure 3.11 Proliferative capacity of the ALDHhi and ALDHlo sorted cell populations 
using the cell cycle marker Ki67.  
(A) Representative images for Ki67 proliferation in the sorted cell populations, labeled 
by DAPI (blue). White arrows indicate K67+ cell staining. Scale bar: 15 µm. (B) 
Quantitative analysis of Ki67+ cells in the total sorted cell populations. Data are 
expressed as mean ± SEM and analyzed using unpaired t-tests (n=3 sorted 
pancreata/group). * p<0.05 vs. ALDHlo sorted populations.  
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3.5 Examination of sorted ALDHhi cells cultured on 
extracellular matrix proteins  
The selected extracellular matrices (ECM) coatings were tested to compare their 
suitability for promoting viability of ALDHhi sorted cells during short-term (24 hours) 
and long-term (5 days) culture conditions (Krishnamurthy et al. 2008). MTT staining was 
used to examine viable adhered cells at 24 hours (Figure 3.12A) and 5 days (Figure 
3.12B) after initial seeding of 1 x104 ALDHhi sorted cells/well. After 24 hours, viable 
adhered cells were scattered throughout wells in the control and ECM cultured groups 
(Figure 3.12A). Adhered cells cultured for a period of 5 days on control and select ECM 
coatings began to demonstrate cell-cell contact, forming viable monolayers; this was 
noticeable on the laminin, collagen I, and collagen IV coatings (Figure 3.12B). Fold 
change for the number of viable adhered cells on each ECM coating at 5 days was 
normalized to the 24 hour groups, and it was found that laminin and collagen I had a 
significantly higher fold change after 5 days of culture (Figure 3.12C). These results 
indicate that the laminin and collagen I coatings are ideal for the long-term promotion of 
viability and expansion in sorted pancreatic cells.  
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Figure 3.12 Effect of extracellular matrices on sorted ALDHhi cell viability after 24 
hours and 5 days of culture.  
Phase-contrast images of ALDHhi sorted cells on control- and select extracellular 
matrices- coated wells at 24 hours (A) and 5 days (B) after initial seeding of wells. MTT 
assays were used to confirm viability of adhered cells (dark blue). Scale bar: 100 µm. (C) 
Fold change of viable adhered cells on control and select extracellular matrices at 5 days. 
Data are expressed as mean ± SEM with an unpaired t-test analysis (n= 3 samples/ECM 
test). *p<0.05, **p<0.01 vs. viable adhered cells at 24 hours.  
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3.6 Characterization of sorted ALDHhi and ALDHlo cells 
expanded in vitro  
Sorted ALDHhi and ALDHlo cell populations cultured for an extended period were 
analyzed to determine if the phenotype seen initially in the ALDHhi sorted cell population 
was maintained during long-term culture and expansion in vitro. During extended culture 
on collagen I–coated wells, the sorted ALDHhi and ALDHlo cells lost the epithelial-like 
cell monolayer and began to demonstrate spindle-shaped morphology (Figure 3.13A). 
Interestingly, both ALDHhi and ALDHlo cultured cells, which had demonstrated CK19 
staining immediately after cell sorting, no longer expressed the CK19 marker in cultured 
cells (Figure 3.13B). The epithelial marker E-cadherin was retained in ALDHhi and 
ALDHlo cultured populations during expanding and passaged cultures, and the 
mesenchymal cell-associated marker vimentin was present in both populations in the 
expanding culture (Figure 3.13B). The presence of E-cadherin and vimentin after culture 
in both populations could imply that these cell types adhered and expanded in an in vitro 
environment, or that these cells had entered epithelial-to-mesenchymal transition (EMT), 
similar to previously reports in islet cell cultures (Gershengorn et al. 2004). qRT-PCR 
analysis of transcription factor expression in expansion culture groups showed relative 
decreases of SOX9, PDX-1, and NKX6.1 in the ALDHhi cultured cells, but maintained 
levels of NGN3 (Figure 3.14). The expression of INS mRNA showed similar levels 
between the ALDHhi and ALDHlo cultured groups, indicating that the difference seen in 
insulin expression immediately after cell sort was lost during the expanding culture 
period (Figure 3.14). Immunofluorescence staining was used to confirm these results as 
well as examine the change in pancreatic cell lineages of cultured cells. The cultured 
ALDHhi and ALDHlo groups retained SOX9 transcription factor immunofluorescence 
expression, but PDX-1, NGN3, and insulin staining were lost after expansion of the 
sorted cell populations (Figure 3.15), suggesting that these cells could be heading away 
from endocrine cell differentiation or that remaining cells belong to a non-endocrine 
pancreatic fate.  
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Figure 3.13 Morphological analysis of sorted ALDHhi and ALDHlo cell populations 
after extended culture.  
(A) Representative phase-contrast image of spindle-shaped cultured cells immediately (0 
days, left) and 3 days (right) after passaging onto collagen I coated wells. Scale bar: 200 
µm. (B) Representative immunofluorescence image for E-cadherin, vimentin, and CK19 
staining on cultured ALDHhi and ALDHlo cell populations. White arrows indicate 
positive cells in cultured population. Scale bar: 25 µm. (n=3-4 culture passages/group)  
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Figure 3.14 Expression of pancreatic transcription factors and hormones after 
expansion of ALDHhi and ALDHlo cells.  
qRT-PCR analysis of SOX9, PDX-1, NGN3, NKX6.1, and INS mRNA expression in 
cultured ALDHhi and ALDHlo cell populations. Data are normalized to the housekeeping 
gene 18S and analyzed using the comparative Ct method. White bars, ALDHhi group; 
black bars, ALDHlo group. Data are expressed as mean ± SEM and analyzed using 
unpaired t-tests (n=4 cultured passages/group)  
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Figure 3.15 Expression of transcription factors and the insulin hormone after 
expansion of ALDHhi and ALDHlo cells. 
Representative immunofluorescence images for SOX9, PDX-1, NGN3, and insulin 
staining in cultured ALDHhi and ALDHlo cell populations. White arrows indicate marked 
nuclei SOX9+ cells. Scale bar: 25 µm. (n=3-4 culture passages/group) 
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3.7 Differentiation of ALDHhi and ALDHlo cultured cells  
To examine if the expanded sorted cells could form islet-like clusters and propagate 
towards β-cell fate, both ALDHhi and ALDHlo expanded cells were treated with 
differentiation medium and cultured for 7 days. Phase-contrast images under the inverted 
microscope demonstrated that islet-like clusters formed as early as 36 hours after 
differentiation medium was added, and large, dense clusters were seen more in the 
ALDHhi group after 7 days of differentiation versus the ALDHlo group (Figure 3.16). To 
determine if there were any changes in transcription factors and insulin gene expression 
after differentiation from cultured ALDHhi and ALDHlo cells, real-time RT-PCR analysis 
was conducted. The expression of PDX-1, NGN3 and INS mRNA was relatively elevated 
in the ALDHhi cell clusters, compared to the ALDHlo clusters (Figure 3.17), but no 
difference was seen when statistically analyzed. Similar expression levels of SOX9 and 
NKX6.1 were observed in those differentiated cell clusters (Figure 3.17). 
Furthermore, immunofluorescence staining was conducted on differentiated ALDHhi and 
ALDHlo cell clusters to examine phenotypic changes that resulted from cluster formation. 
The weak expression of CK19, which was lost during the expansion of both cultured 
groups, was noted in both ALDHhi and ALDHlo clusters (Figure 3.18). Vimentin and E-
cadherin were co-stained and still present in clusters after differentiation culture (Figure 
3.18), implying that the mesenchymal-epithelial cell switch occurs during the 
differentiation culture in both ALDHhi and ALDHlo clusters. Weak SOX9+ staining could 
also be seen in the clusters and single cells from the ALDHhi and ALDHlo differentiated 
groups (Figure 3.18).  
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Figure 3.16 Islet-like cluster formation during differentiation of cultured ALDHhi 
and ALDHlo cells.  
Representative phase-contrast images of single cells to cluster formation in cultured 
ALDHhi and ALDHlo cells at 0 hours, 36 hours, and 7 days following differentiation 
medium exposure. Scale bar: 200 µm.  
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Figure 3.17 Expression of pancreatic transcription factors and hormone in islet-like 
clusters.  
qRT-PCR analysis of SOX9, PDX-1, NGN3, NKX6.1, and INS mRNA expression in 
ALDHhi and ALDHlo clustered cells after a 7-day period in differentiation media. Data 
are normalized to the housekeeping gene 18S and analyzed using the comparative Ct 
method. White bars, ALDHhi group; black bars, ALDHlo group. Data are expressed as 
mean ± SEM and analyzed using unpaired t-tests (mean ± SEM; n=3-5 cultured passages 
/group)  
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Figure 3.18 Morphological analysis of ALDHhi and ALDHlo clustered cells cultured 
in differentiating media for 7 days. 
 Representative immunofluorescence staining for CK19, E-cadherin, and SOX9 (green), 
and vimentin (red). Nuclei are stained by DAPI (blue). White arrows indicate CK19+, E-
cadherin+, and SOX9+ cells, while yellow arrows indicate vimentin+ cells. Scale bar: 15 
µm. (n=3 culture passages/group) 
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3.8 Examination and analysis of transplanted ALDHhi and 
ALDHlo sorted populations  
Transplantation of fibrin-wrapped sorted populations into nude mice hosts was done to 
determine the effect that an in vivo environment would have on the phenotype of the 
ALDHhi population and differentiation towards the β-cell fate. ALDHhi and ALDHlo 
sorted cells wrapped in fibrin gel were analyzed at 24 hours of culture and 1 week after 
subcutaneous transplantation. It is noted that CD31+ cells were highly expressed in the 
ALDHlo sorted cells compared to ALDHhi cell population (Figure 3.19A). CD31+ cells 
were observed after 24h culture in fibrin gel and 1 week after subcutaneous 
transplantation of the ALDHlo graft, and co-localization of the human-specific 
mitochondria marker HMS with CD31 was also seen occasionally in these grafts (Figure 
3.19B), suggesting that vascularization is promoted in the ALDHlo sorted population. 
Both fibrin-wrapped ALDHhi and ALDHlo cell grafts were clearly observed under the 
skin of the nude mice (Figure 3.19C). However, abundant vasculature formed around the 
fibrin-wrapped ALDHlo cell graft and was clearly visible (Figure 3.19C, right) when 
compared to the fibrin-wrapped ALDHhi cell graft (Figure 3.19C, left). Double 
immunofluorescence staining for Insulin and HMS (not shown) showed no noticeable 
change in co-localization or phenotype when compared to the sorted cells analyzed 
immediately after sort (0 hrs), and examination of the transplanted gels for these markers 
resulted in no bulk cell expression in either sorted cell group, demonstrating loss of 
insulin+ cells in the gel. 
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Figure 3.19 Analysis of an in vivo environment on vascularization in sorted and 
transplanted cells. (A) Representative immunofluorescence images for CD31staining in 
sorted ALDHhi and ALDHlo populations (0 hours). White arrows, CD31+ staining in 
population. Scale bar: 15 µm. (n=2-3 sorted populations/group). (B) Representative 
immunofluorescence images of CD31 (green) and HMS (red) staining in fibrin-gel 
wrapped sorted cells after 24 hours in culture and 1 week after subcutaneous 
transplantation. White arrow, positive staining in population. Yellow arrow, double 
positive staining. Dashed lines indicate co-localization of CD31 and HMS. Scale bar: 15 
µm. (C) Representative graph images of vascularization in fibrin-wrapped ALDHhi and 
ALDHlo sorted cells after 1 week of subcutaneous transplantation in nude mice, graphs 
outlined by dashed lines (n=5 sorted populations/group).   
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Chapter 4 - Discussion 
The purpose of this project was to examine the distribution of surface stem cell markers 
and endocrine-specific transcription factors in the ALDHhi sorted cell populations of the 
human fetal pancreas. This thesis hypothesized that ALDHhi cells represent a progenitor 
cell pool in the developing human pancreas that co-localizes with other established stem 
cell surface markers, expresses factors specific for endocrine cell differentiation, and 
propagates an endocrine cell population in vitro and in vivo. Using FACS and 
immunofluorescence staining to analyze the sorted populations, this thesis demonstrated 
that ALDHhi cells co-localized with stem cell markers (CD133), transcription factors 
(SOX9, PDX-1, NKX6.1), and endocrine hormones (insulin and somatostatin). Extended 
culture of ALDHhi sorted cells resulted in changes to the pancreatic cell population’s 
phenotype characterized immediately after sort, but differentiation induced cluster 
formation and restoration of some transcription factor expression in the expanded 
ALDHhi group. In summary, these results indicate that the ALDHhi cells of the human 
fetal pancreas could represent a potential endocrine precursor cell pool during pancreatic 
development. The following discussion section will address the five specific questions 
originally introduced at the beginning of this thesis.  
4.1    Do CD133, CD34, or CD117 co-localize exclusively 
with the ALDHhi populations in dissociated human fetal 
pancreatic cells? 
Analysis of the co-localization of established surface stem cell markers with ALDHhi 
human fetal pancreatic cells supports the categorization of this cell type as a precursor 
cell population during development. The co-staining of Aldefluor-treated pancreatic 
sorted cells against surface stem cell markers CD133, CD34, and CD117 resulted in 
distinctive expression of all three surface markers on ALDHhi sorted cells. However, this 
study only captures the later stages of human pancreatic development from 18 to 22 
weeks of fetal age. The morphology of the pancreas in earlier stages (8 to 11 weeks of 
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fetal age) is vastly different from the more mature later stage organ, as examined 
previously (Lyttle et al. 2008), and the higher expression of ALDH in earlier 
developmental stages (Li et al. 2014) could affect co-localization percentages with these 
stem cell markers. For an accurate representation of ALDH and stem cell marker 
expression in the human fetal pancreas, the pancreas should be assessed during different 
developmental stages.  
The highest percentage of co-localization was seen in CD133+ cells within the ALDHhi 
sorted population, which correlated with our previous report in the human fetal pancreas 
(Li et al. 2014). CD133+ cells in mESCs have been attributed as being not fully 
differentiated (Kania et al. 2005), which supports the work that the ALDHhi population 
with high CD133+ signals in the developing pancreas could represent a pool of 
developmentally immature precursor cells. Due to the advanced morphology of the 
pancreas at this fetal age, the CD133+ cell population could also be composed of the 
established ductal structures previously reported in human fetal pancreata (Sugiyama et 
al. 2007). This indicates that the ALDHhi/CD133+ sorted cell population represents a 
heterogeneous pancreatic precursor pool. However, NGN3+ cells have been found in the 
ductal cells that express CD133 (Sugiyama et al. 2007), implying that endocrine cells can 
develop from this population. Furthermore, the percent of CD133+ cells that do not co-
localize with ALDHhi cells is small, indicating that CD133+ cells are almost always found 
on cells with high ALDH activity during later stages of pancreatic development. Thus, 
the ALDHhi/CD133+ sorted population could denote one population for isolating a 
pancreatic precursor pool that can differentiate towards endocrine cell fate, due to both 
markers’ associations with islet cell production and the co-localization exclusivity seen 
during late stage development.  
It is noted that only ~25% of ALDHhi cells co-localized with CD34; however, a 
significantly higher number of CD34+ cells are found in the ALDHlo cell population. The 
association of CD34 with pancreatic progenitor cells is complex, since CD34+ cells 
isolated from the murine pancreas can give rise to endothelial cells in culture (Oshima et 
al. 2007). Our previous study also found that endothelial cells (identified by CD31+ cells) 
did not co-localize with ALDH in the developing human pancreas (Li et al. 2014), 
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suggesting that ALDHlo/CD34+ population may represent a progenitor pool for 
endothelial development. It is possible that the smaller ALDHhi/CD34+ population could 
be specifically related to endocrine cell differentiation, but there are not enough 
published results to support this statement. Thus, further studies are needed to analyze the 
composition of this population immediately after sort and examine its overlap with 
known endothelial cell markers.  
Unlike CD133 and CD34, the marker CD117 is relatively unchanged between the sorted 
ALDHhi and ALDHlo populations. The percentage of CD117+ cells in both populations 
also varied heavily between sorts. This data does not agree with our previous study where 
ALDHhi cells had significantly high co-localization with of CD117+ cells compared to the 
ALDHlo population (Li et al. 2014). One possible explanation for this difference is that 
sampled pancreata were acquired from different age groups; the previous study used 
pancreata from 13 to 22 weeks of fetal age, while this study used pancreata from 18 to 22 
weeks. It is also important to note that there is a significant age-dependent decrease of 
CD117 expression in certain parts of the pancreas as age increases (Li et al. 2007). This 
could indicate that the later stage pancreata examined during this study no longer contain 
a sortable CD117+ population, and that the ALDHhi/CD117+ sorted population, though it 
could contain endocrine precursor characteristics, does not represent a significant 
population of pancreatic cells at this fetal age. The ALDHhi/CD34+ and ALDHhi/CD117+ 
cells could be analyzed for endocrine precursor potential, but the goal of this study was to 
identify surface stem cell markers that co-localized highly with ALDHhi cells during 
development at this fetal age. Therefore, future studies should primarily focus on 
characterizing ALDHhi/CD133+ sorted cells. 
The co-localization of CD133, CD34, and CD117 on ALDHhi and ALDHlo sorted cells 
was essential for examining if they exclusively co-localized with the ALDH populations, 
or if there was significant overlap between the surface cell markers. When analyzing the 
sorted populations, it was seen that CD117+/CD34+ cells had the highest co-localization 
in both the ALDHhi and ALDHlo groups, while CD133+/CD117+ and CD34+/CD133+ 
cells co-localized in both groups at a lower frequency, demonstrating that none of the 
selected surface stem cell markers are independent from one another in the sorted 
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populations. Co-localization of these markers with the ALDHhi group has not been 
previously examined in the developing pancreas, but ALDHhi/CD133+/CD34+/CD117+ 
umbilical cord blood hematopoietic stem cells have been shown to improve diabetic 
conditions when transplanted into murine pancreata (Bell et al. 2012). This suggests that 
the overlapping populations of surface stem cell markers in the sorted ALDHhi cells aid in 
improving islet regeneration in damaged islets, and that ALDHhi populations with more 
than one stem cell marker attributed to them could be an important cell pool for 
regeneration and repair therapies in diabetics.  
4.2    Does the ALDHhi sorted population contain TFs 
necessary for endocrine cell development? 
An established set of transcription factors necessary for endocrine cell development has 
been reported in whole sections of the human fetal pancreas (Lyttle et al. 2008) and has 
also been briefly examined in co-localized ALDH cells of whole fetal pancreatic tissue 
(Li et al. 2014), but has not been characterized in sorted cells with ALDHhi activity. The 
results from qRT-PCR analysis demonstrated relatively increased gene expression of TFs 
important for endocrine cell differentiation in the ALDHhi sorted cells, which correlates 
with data gathered from immunofluorescence staining; however, none of them showed 
statistically significant differences between ALDHhi and ALDHlo populations at the 
mRNA level. The possible reasons associated with this result may be explained due to the 
following: (1) the extracted RNA concentrations from sorted single cells were lower (0.1-
0.2 µg/µl) than those gathered from whole pancreas samples; (2) the fetal ages of 
gathered samples demonstrated extreme variability due to being separated by up to four 
weeks in developmental age; and (3) low cell viability after cell sorting.  
Immunofluorescence staining was used to confirm the mRNA expression results and to 
detect transcription factor activity in the nuclei of sorted populations. There are a number 
of transcription factors that were highly expressed in the ALDHhi sorted population, 
including SOX9, PDX-1, NGN3, NKX6.1 and PAX6. SOX9 was the transcription factor 
with the highest nuclear presence in ALDHhi cells. The SOX transcription factor class has 
been heavily associated with propagating pancreatic development (McDonald et al. 
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2009). SOX9, which is up-regulated during early fetal pancreatic development and is 
reduced significantly with age (McDonald et al. 2012), has been previously linked to 
ALDH activity within a breast cancer-derived cell line, where treating cells with ATRA 
resulted in an increase of SOX9 mRNA (Muller et al. 2010). This correlates with our 
ALDH study, where DEAB treatment of isolated fetal islet-epithelial clusters reduced the 
number of SOX9+ cells (Li et al. 2014). The results from previous research combined 
with the results from this study indicate that SOX9 can be regulated by retinoic acid, and 
that ALDH activity encourages SOX9 expression during development. It is also 
important to note that the ALDHlo sorted cells also contain a small SOX9+ cell 
population. The expression of SOX9 in the pancreas can be induced by factors other than 
retinoic acid, notably through Fgf10-Fgfr2b signaling (Seymour et al. 2012, Belo et al. 
2013). Thus, there could be a complex signaling network driving SOX9 expression, 
where SOX9 activity can be dependent or independent of retinoic acid production. 
Since SOX9 is a transcription factor associated with pancreatic progenitors, its high 
percentage in the ALDHhi sorted population indicates that this group contains a 
significant portion of precursor cells. One progenitor fate that SOX9 populations could 
represent is the endocrine cell-producing ductal epithelium, due to the high number of 
CD133+ cells in the ALDHhi population and the localization of SOX9 in ductal cells 
during development (Sugiyama et al. 2007, Lardon et al. 2008, Kopp et al. 2011). SOX9 
expression is also associated with NGN3+ and insulin+ cells as determined previously by 
over-expression and knockdown of SOX9 in islet-like cell clusters, indicating its role in 
β-cell development (McDonald et al. 2012). However, a higher number of PDX-1+, 
NGN3+, NKX6.1+, and insulin+ cells were seen in the ALDHhi group, all previously 
associated with promoting insulin+ cell-like fate (Lyttle et al. 2008). Previous research 
reported an increase of the transcription factors PDX-1 and NGN3 during the 
differentiation of isolated islet-like clusters from human fetal pancreata (Zhang et al. 
2013), reflecting their up-regulation during the commitment towards islet cell fate in the 
pancreas. This information, combined with this thesis’s results, indicates that ALDHhi 
sorted cells have a higher population of cells currently differentiating towards insulin-
secreting cell fate. Endocrine precursor cells tend to lose their SOX9 expression once 
NGN3 activity is up-regulated (Shih et al. 2012, Belo et al. 2013), therefore the NGN3+ 
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population in the ALDHhi sorted group could be derived from the SOX9+ cells. Although 
SOX9 expression decreases in NGN3+ and insulin+ cells in later stages of development 
(McDonald et al. 2012), it is still seen in the sorted late stage cells, suggesting that 
SOX9+ cells in the ALDHhi sorted group continue to contribute to the precursor cell pool. 
Indeed, our previous study found that the number of insulin+ cells in isolated islet-
epithelial clusters was up-regulated by increasing ALDH activity and the presence of 
retinoic acid (Li et al. 2014); these results parallel the SOX9 research done on the same 
cell source, where increases of Insulin expression were observed with SOX9 
overexpression (McDonald et al. 2012). Therefore, the higher association of insulin cells 
in the ALDHhi sorted population could be promoted due to the high ALDHhi/SOX9+ co-
localization in the sorted population.  
4.3   Could ALDHhi cells maintain their phenotypes during 
culture in vitro? 
Extracellular matrix (ECM) proteins are present during structural development of the 
pancreas (Hisaoka et al. 1993) and have previously been used to increase cell survival in 
ex vivo culture conditions (Pinkse et al. 2006). By modifying the protocol from 
Krishnamurthy et al. (2008), this study found that viability and expansion of the ALDHhi 
sorted population significantly improved when cultured on laminin and collagen I coated 
wells. Collagen I has been shown to improve viability, proliferation, and function of INS-
1 cells to maintain their cell phenotype (Krishnamurthy et al. 2008). Therefore, this study 
used collagen I matrix coating for ALDHhi and ALDHlo sorted cell culture and expansion. 
Interestingly, the expanded ALDHhi and ALDHlo sorted cells resulted in the formation of 
spindle-like monolayers in wells. Similar monolayers were also observed in other human 
islet pancreas studies (Gershengorn et al. 2004, Joglekar et al. 2009). Both ALDHhi and 
ALDHlo expanded cell populations showed vimentin and E-cadherin as well as the loss of 
CK19, indicating epithelial cell and mesenchymal phenotypes during culture. This could 
indicate that both cultured cell populations, which demonstrated similar cell lineage 
phenotypes of E-cadherin and β-catenin immediately after sort, enter epithelial-to-
mesenchymal transition (EMT) for the purpose of expanding the population. There is 
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established evidence demonstrating that insulin-expressing cells from plated islets can 
enter EMT (Gershengorn et al. 2004). Additional research also showed correlations 
between the mesenchymal marker vimentin and the presence of insulin (Davani et al 
2007, Cole et al. 2009). This could also account for the loss of CK19 from the cultured 
populations. However, a few vimentin+ cells were present in the ALDHhi sorted 
population, and these cells could have adhered and successfully expanded from the initial 
seeded population, and thus the presence of vimentin may not necessarily indicate EMT. 
Previous research demonstrated that β-cells from isolated islets do not enter EMT and 
thus do not form mesenchymal cells (Atouf et al 2007). At least two possibilities could 
account for the presence of mesenchymal markers in the cultured cell population: initial 
mesenchymal cells from the original population that have expanded alongside e-
cadherin+ cells, or EMT as verified in differentiation experiments, where CK19+ cells 
were restored in expanded cells that formed cell clusters. 
Examining the mRNA expression of transcription factors in cells after extended culture 
resulted in maintained NGN3 expression in the ALDHhi group. One possibility for this 
could be due to the reported relationship between SOX9 and NGN3 expression in cells, 
since SOX9 is still present as determined by immunofluorescence staining of the 
expanded populations. Sox9 in developing murine pancreata is important for Ngn3 
production, and increased Ngn3 led to down-regulated Sox9 expression (Shih et al. 
2012). This could indicate that cultured cells from the ALDHhi population may continue 
with commitment to the endocrine cell fate, and once again implies that the SOX9+ cells 
in the ALDHhi population are primed precursors for endocrine cell differentiation. 
However, the decrease in NKX6.1 and the low expression of Insulin do not indicate β-cell 
specificity. Therefore, the retained presence of SOX9 after cell culture expansion could 
indicate an early endocrine precursor fate that can reach islet cell specificity when treated 
with differentiation factors, and this will be examined in the next section.  
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4.4    Do ALDHhi cultured cells give rise to islet-like cell 
clusters?  
The formation of clusters was seen in ALDHhi wells when treated with media previously 
applied to initiate islet-like cluster differentiation (Gershengorn et al. 2004, Wu et al. 
2010), though the ALDHlo population also had cluster formation. In vitro studies in 
different neoplastic populations have found increased sphere formation in ALDHhi 
neoplastic cultures when compared to the ALDHlo colonies (Li et al. 2010, Soehngen et 
al. 2013). The mRNA expression of transcription factors PDX-1 and NGN3, and the 
hormone Insulin, in the ALDHhi cluster group suggests that the ALDHhi group is primed 
towards endocrine cell differentiation after cluster formation. These changes detected at 
the level of gene expression reflect the NGN3 increase in ALDHhi expanded cells, and 
further reflect the importance of NGN3 as an endocrine precursor factor.   
Strong immunofluorescence staining for E-cadherin and vimentin demonstrated that the 
mesenchymal and epithelial cells seen during undifferentiated culture and expansion were 
still present in ALDHhi and ALDHlo clusters, which corresponds to previous cluster 
differentiation retaining Vimentin expression (Gershengorn et al. 2004). CK19 and SOX9 
expression were seen in differentiated clusters, and the relationship between the two 
during development should also be considered for these clustered cells, since SOX9+ 
cells in the duct have been reported as a pancreatic cell precursor pool that can contribute 
to β-cell production during development (Kopp et al. 2011), and have a debated role 
regarding β-cell production in injured adult pancreata (Kopp et al. 2011, Van de Casteele 
et al. 2014). One interesting point to note is that SOX9 is retained at the protein level, but 
there is no change between ALDHhi and ALDHlo cluster SOX9 mRNA. It can be 
concluded from the expanded and differentiated data that SOX9 activity retains a 
pancreatic precursor fate that has the ability to form endocrine precursor cells. This study 
also demonstrated that specific culture conditions are needed to begin cell differentiation 
towards endocrine fate, and that SOX9 and NGN3 expression are important, but not 
sufficient, for cell commitment. Additional differentiation factors that have demonstrated 
insulin+ cell production, like nicotinamide (Ye et al. 2006) and taurine (Gopurappilly et 
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al. 2013), could be implemented to further stimulate these clusters towards a β-cell–like 
fate.  
4.5    Does the subcutaneous transplantation of ALDHhi 
sorted cells, wrapped in fibrin gel, enhance differentiation 
towards the endocrine cell type in nude mice? 
Positive results have been reported in experiments combining a three-dimensional matrix 
system to support isolated islets in vitro and in vivo (Daoud et al. 2011, Hosseini-
Tabatabaei et al. 2013, Riopel et al. 2013), so fibrin gels were implemented in the sorted 
populations to examine their differentiation potential in vivo. However, insulin staining 
was not seen in the cells after transplantation. There are many possible reasons as to why 
this was seen, including: 1) the low amount of cells transplanted into each graft; 2) the 
transplantation time interval in the host mouse could affect the differentiation potential of 
the sorted cells; and 3) the nude mice were in a normal glucose metabolic status, and thus 
the drive towards insulin+ cells was not required. NKX6.1hi hESCs transplanted into mice 
for a 5-month time period were able to develop into endocrine cells that restored glucose 
tolerance in diabetic mice (Rezania et al. 2013), suggesting that cells may need a specific 
incubation time and a diabetic situation to develop in vivo.  
The most significant change observed between the sorted cell groups was the 
vascularization seen in ALDHlo fibrin-wrapped sorted cells. The lack of CD31 in the 
ALDHhi population has been reported in our previous study (Li et al. 2014), and this 
result correlates to the current study and shows that ALDHhi cells do not promote 
vascularization. CD34 is heavily associated with developing vasculature in the human 
fetal pancreas, and has been shown to associate closely with developing islets (Piper et al. 
2004, Sarkar et al. 2008). This is one possible reason as to why there is higher co-
localization of CD34 in the ALDHlo sorted group. Therefore, further analysis should be 
conducted in the ALDHlo group to determine the co-localizaton of CD34 with CD31.  
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4.6    Proposed mechanism of ALDHhi cell activity in the 
human fetal pancreas  
By characterizing the ALDHhi sorted population and analyzing the changes seen in 
culture, in clusters, and when transplanted, a mechanism for ALDH activity in the 
developing human fetal pancreata is proposed below (Figure 4.1). In the developing 
human fetal pancreata (18-22 weeks of fetal age), ALDHhi sorted cells represent a 
CD133+ pancreatic population, with an enriched pool of endocrine precursor cells. In 
contrast, the ALDHlo sorted group primarily co-localizes with the CD34 marker and 
contains a higher population of cells expressing mesenchymal and endothelial cell fate 
markers. Both populations contain epithelial cells, which may house the remaining ductal 
and acinar tissue in the sorted cells. This information demonstrates that separation of 
ALDHhi cells from the total pancreatic population isolates a unique precursor source of 
cells geared towards endocrine cell differentiation.  
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Figure 4.1 Proposed fate commitment of cells with varying ALDH activity during 
human fetal pancreatic development. The ALDHhi developing population contains 
CD133-enriched cells and a pool of endocrine precursor cells. Additionally, the ALDHlo 
group expresses high levels of CD34 and represents a significant mesenchymal cell pool.  
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4.7    Limitations encountered in this thesis  
Although FACS has previously been performed in ALDHhi cells from different cell types, 
extensive studies that solely utilize sorted ALDHhi cells from the human fetal pancreas 
had not been attempted. Established protocols had to be optimized since the sorted cells 
used were from a primary developing organ source. One limitation mentioned earlier was 
the unavoidable prolonged incubation of dissociated fetal cells. Maintaining these cells in 
this traumatized state may not have only affected the cell viability, but could have 
skewed the cellular composition of the final sorted population. Previous cell sorts 
demonstrated that almost half of the ALDHhi sorted group were E-cadherin+ cells (Li et 
al. 2014), unlike the results of this thesis that found less than 10% of E-cadherin+ cells 
were in the ALDHhi group. Furthermore, exocrine markers that have been previously 
found in the human fetal pancreas were not visible in the ALDHhi or ALDHlo sorted 
groups when using immunofluorescence labeling, although they were visible in ALDHhi 
and ALDHlo cells of whole fetal pancreas sections (Li et al. 2014). This is another critical 
limitation of this study due to the unknown percentage of ALDHhi sorted cells that 
expressed exocrine markers, and challenges using ALDHhi cells as precursor markers for 
endocrine fate since this population could also give rise to a significant number of 
exocrine cells as well. It is possible that the cells expressing exocrine markers were 
excluded from the sorts due to poor viability of this cell type. One solution for examining 
the whole cell composition of the sorted pancreas is to fluorescently label specific 
markers of each cell type (ex: using E-cadherin for epithelial cells) and analyze their 
expression during FACS. This will be able to tell us if the populations are at least present 
in the whole tissue sample, even if they are not viable sorted cells.   
Due to the precise nature of cell sorting and the strict removal of all cells that do not fall 
within the gated populations of interest, a large amount of cells are excluded from the 
sorted population, which results in a low final cell number in both the ALDHhi and 
ALDHlo sorted populations. This resulted in sample limitations for all following 
experiments, including low RNA concentrations for qRT-PCR, smaller sample sizes for 
immunofluorescence analysis, and a limited number of cells for transplanted fibrin-
wrapped sorted gels. Although the solutions for tackling these limitations are restricted, it 
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is possible to increase the sorted number without including cells outside of the sorted 
gates (and thus introducing cell populations that could contaminate the purity of the 
marker being examined) by merging fetal pancreatic samples of similar developmental 
ages. Proceeding with this introduces an additional limitation to this study: obtaining 
human fetal pancreata is difficult, so merging samples reduces the sample size number 
examined. It is also important to consider the unique development of each individual 
pancreas and the possibility of skewing results due to this. Genetic and maternal 
differences will be different between the samples, and these changes have the possibility 
of strongly affecting fetal development.   
Finally, challenges associated with culturing the sorted populations for expansion and 
differentiation were encountered. Expanding the sorted ALDHhi and ALDHlo populations 
did not maintain their phenotypes immediately seen after sort, and resulted in a loss of 
ALDH activity. In addition, the transcription factor expression differences observed 
between ALDHhi and ALDHlo populations was also lost, meaning that further studies 
examining a larger population of these cells was not feasible without exogenous 
stimulation towards differentiation. While clustering of these expanded cells allowed for 
limited differentiation towards the endocrine cell fate, maintenance of these clusters was 
difficult to continue. Extended exposure to the serum-free medium not only reduced cell 
proliferation in previous experiments, but also increased cellular death at day 7 of 
differentiation (Wu et al. 2010). Using three-dimensional matrices to house these clusters 
after initial differentiation could be one method to extend cell viability and prolong cell 
proliferation in vitro, since this method has demonstrated some success in past studies 
(Riopel et al. 2013). 
4.8    Future studies and concluding remarks  
This thesis characterizes the surface stem cell markers, transcription factors, and 
hormones associated with ALDHhi sorted cells of the human fetal pancreas, and examines 
the maintenance of their phenotype in vitro and in vivo. The high co-localization of 
ALDHhi sorted cells with cell markers, notably CD133, and their high expression of 
SOX9 supports their role as a precursor for pancreatic cell fate. Analyzing endocrine-
81 
 
linked markers and concluding that the ALDHhi sorted population had a high percentage 
of islet-specific transcription factors and hormone cells indicates the suitability of using 
ALDH activity as a marker for isolating endocrine precursors. In addition, prolonged 
culture of ALDHhi cells decreases pancreatic transcription factor expression and can 
encourage EMT conditions, but stimulation of cluster formation restores endocrine 
progenitor fate. Further studies should be conducted that focus on examining 
ALDHhi/CD133+ cells as ideal candidates for the generation of islet cells. By 
characterizing the ALDHhi/CD133+ sorted cell populations, it will be possible to compare 
the percentage of islet cell transcription factors and hormone cells to the ALDHhi sorted 
cells and see if the ALDHhi/CD133+ population has a specific commitment towards 
endocrine cell fate. Furthermore, the ALDHhi/CD133+ cells should be examined in an in 
vitro and in vivo environment to see if they display the phenotype that retains the 
expression of the pancreatic progenitor marker SOX9 as well as endocrine cell markers, 
allowing for the generation of islet cells. As a final point, transplantation of the 
differentiated ALDHhi and ALDHlo clusters wrapped in fibrin gel would be interesting to 
examine in order to see if an in vivo environment would encourage differentiation 
towards insulin-producing β-like cell clusters.  
 
82 
 
Chapter 5 -References 
 
Adda G, Hannoun L, Loygue J. 1984. Development of the human pancreas: Variations 
and pathology. A tentative classification. Anat Clin 5(4):275-83. 
 
Afrikanova I, Kayali A, Lopez A, Hayek A. 2012. Is stage-specific embryonic antigen 4 a 
marker for human ductal stem/progenitor cells? Biores Open Access 1(4):184-91. 
 
Ahlgren U, Pfaff SL, Jessell TM, Edlund T, Edlund H. 1997. Independent requirement 
for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature 385(6613):257-
60. 
 
Al-Masri M, Krishnamurthy M, Li J, Fellows GF, Dong HH, Goodyer CG, Wang R. 
2010. Effect of forkhead box O1 (FOXO1) on beta cell development in the human fetal 
pancreas. Diabetologia 53(4):699-711. 
 
Alamgeer M, Ganju V, Szczepny A, Russell PA, Prodanovic Z, Kumar B, Wainer Z, 
Brown T, Schneider-Kolsky M, Conron M, et al. 2013. The prognostic significance of 
aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-
small cell lung cancer. Thorax 68(12):1095-104. 
 
Andralojc KM, Mercalli A, Nowak KW, Albarello L, Calcagno R, Luzi L, Bonifacio E, 
Doglioni C, Piemonti L. 2009. Ghrelin-producing epsilon cells in the developing and 
adult human pancreas. Diabetologia 52(3):486-93. 
 
Andrews PW. 1984. Retinoic acid induces neuronal differentiation of a cloned human 
embryonal carcinoma cell line in vitro. Dev Biol 103(2):285-93. 
 
Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, Hrabe de Angelis M, 
Lendahl U, Edlund H. 1999. Notch signalling controls pancreatic cell differentiation. 
Nature 400(6747):877-81. 
 
Apte MV, Pirola RC, Wilson JS. 2012. Pancreatic stellate cells: A starring role in normal 
and diseased pancreas. Front Physiol 3:344. 
 
Armstrong L, Stojkovic M, Dimmick I, Ahmad S, Stojkovic P, Hole N, Lako M. 2004. 
Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated 
on basis of aldehyde dehydrogenase activity. Stem Cells 22(7):1142-51. 
 
Atouf F, Park CH, Pechhold K, Ta M, Choi Y, Lumelsky NL. 2007. No evidence for 
mouse pancreatic beta-cell epithelial-mesenchymal transition in vitro. Diabetes 
56(3):699-702. 
 
83 
 
Balicki D. 2007. Moving forward in human mammary stem cell biology and breast 
cancer prognostication using ALDH1. Cell Stem Cell 1(5):485-7. 
 
Barraud P, Stott S, Mollgard K, Parmar M, Bjorklund A. 2007. In vitro characterization 
of a human neural progenitor cell coexpressing SSEA4 and CD133. J Neurosci Res 
85(2):250-9. 
 
Barth PJ, Ebrahimsade S, Hellinger A, Moll R, Ramaswamy A. 2002. CD34+ fibrocytes 
in neoplastic and inflammatory pancreatic lesions. Virchows Arch 440(2):128-33. 
 
Bell GI, Meschino MT, Hughes-Large JM, Broughton HC, Xenocostas A, Hess DA. 
2012. Combinatorial human progenitor cell transplantation optimizes islet regeneration 
through secretion of paracrine factors. Stem Cells Dev 21(11):1863-76. 
 
Belo J, Krishnamurthy M, Oakie A, Wang R. 2013. The role of SOX9 transcription factor 
in pancreatic and duodenal development. Stem Cells Dev 22(22):2935-43. 
 
Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C. 1995. Essential role for 
the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 
376(6543):768-71. 
 
Blyszczuk P, Czyz J, Kania G, Wagner M, Roll U, St-Onge L, Wobus AM. 2003. 
Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive 
progenitor and insulin-producing cells. Proc Natl Acad Sci U S A 100(3):998-1003. 
 
Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE. 1993. A second pathway for 
regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of 
embryonic development. Diabetes 42(12):1715-20. 
 
Bouwens L, Lu WG, De Krijger R. 1997. Proliferation and differentiation in the human 
fetal endocrine pancreas. Diabetologia 40(4):398-404. 
 
Brissova M, Fowler MJ, Nicholson WE, Chu A, Hirshberg B, Harlan DM, Powers AC. 
2005. Assessment of human pancreatic islet architecture and composition by laser 
scanning confocal microscopy. J Histochem Cytochem 53(9):1087-97. 
 
Burger PE, Gupta R, Xiong X, Ontiveros CS, Salm SN, Moscatelli D, Wilson EL. 2009. 
High aldehyde dehydrogenase activity: A novel functional marker of murine prostate 
stem/progenitor cells. Stem Cells 27(9):2220-8. 
 
Burlison JS, Long Q, Fujitani Y, Wright CV, Magnuson MA. 2008. Pdx-1 and Ptf1a 
concurrently determine fate specification of pancreatic multipotent progenitor cells. Dev 
Biol 316(1):74-86. 
 
84 
 
Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A. 2006. The 
unique cytoarchitecture of human pancreatic islets has implications for islet cell function. 
Proc Natl Acad Sci U S A 103(7):2334-9. 
 
Cai J, Yu C, Liu Y, Chen S, Guo Y, Yong J, Lu W, Ding M, Deng H. 2010. Generation 
of homogeneous PDX1(+) pancreatic progenitors from human ES cell-derived endoderm 
cells. J Mol Cell Biol 2(1):50-60. 
 
Castaing M, Duvillie B, Quemeneur E, Basmaciogullari A, Scharfmann R. 2005. Ex vivo 
analysis of acinar and endocrine cell development in the human embryonic pancreas. Dev 
Dyn 234(2):339-45. 
 
Cheng X, Ying L, Lu L, Galvao AM, Mills JA, Lin HC, Kotton DN, Shen SS, Nostro 
MC, Choi JK, et al. 2012. Self-renewing endodermal progenitor lines generated from 
human pluripotent stem cells. Cell Stem Cell 10(4):371-84. 
 
Chiang CP, Wu CW, Lee SP, Chung CC, Wang CW, Lee SL, Nieh S, Yin SJ. 2009. 
Expression pattern, ethanol-metabolizing activities, and cellular localization of alcohol 
and aldehyde dehydrogenases in human pancreas: Implications for pathogenesis of 
alcohol-induced pancreatic injury. Alcohol Clin Exp Res 33(6):1059-68. 
 
Chute JP, Muramoto GG, Whitesides J, Colvin M, Safi R, Chao NJ, McDonnell DP. 
2006. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion 
of human hematopoietic stem cells. Proc Natl Acad Sci U S A 103(31):11707-12. 
 
Cole L, Anderson M, Antin PB, Limesand SW. 2009. One process for pancreatic beta-
cell coalescence into islets involves an epithelial-mesenchymal transition. J Endocrinol 
203(1):19-31. 
 
Collombat P, Mansouri A, Hecksher-Sorensen J, Serup P, Krull J, Gradwohl G, Gruss P. 
2003. Opposing actions of arx and Pax4 in endocrine pancreas development. Genes Dev 
17(20):2591-603. 
 
Collombat P, Hecksher-Sorensen J, Broccoli V, Krull J, Ponte I, Mundiger T, Smith J, 
Gruss P, Serup P, Mansouri A. 2005. The simultaneous loss of arx and Pax4 genes 
promotes a somatostatin-producing cell fate specification at the expense of the alpha- and 
beta-cell lineages in the mouse endocrine pancreas. Development 132(13):2969-80. 
 
Corti S, Locatelli F, Papadimitriou D, Donadoni C, Salani S, Del Bo R, Strazzer S, 
Bresolin N, Comi GP. 2006. Identification of a primitive brain-derived neural stem cell 
population based on aldehyde dehydrogenase activity. Stem Cells 24(4):975-85. 
 
Croker AK and Allan AL. 2012. Inhibition of aldehyde dehydrogenase (ALDH) activity 
reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44(+) human 
breast cancer cells. Breast Cancer Res Treat 133(1):75-87. 
 
85 
 
D'Amour KA, Bang AG, Eliazer S, Kelly OG, Agulnick AD, Smart NG, Moorman MA, 
Kroon E, Carpenter MK, Baetge EE. 2006. Production of pancreatic hormone-expressing 
endocrine cells from human embryonic stem cells. Nat Biotechnol 24(11):1392-401. 
 
Daoud JT, Petropavlovskaia MS, Patapas JM, Degrandpre CE, Diraddo RW, Rosenberg 
L, Tabrizian M. 2011. Long-term in vitro human pancreatic islet culture using three-
dimensional microfabricated scaffolds. Biomaterials 32(6):1536-42. 
 
Davani B, Ikonomou L, Raaka BM, Geras-Raaka E, Morton RA, Marcus-Samuels B, 
Gershengorn MC. 2007. Human islet-derived precursor cells are mesenchymal stromal 
cells that differentiate and mature to hormone-expressing cells in vivo. Stem Cells 
25(12):3215-22. 
 
Deng S, Yang X, Lassus H, Liang S, Kaur S, Ye Q, Li C, Wang LP, Roby KF, Orsulic S, 
et al. 2010. Distinct expression levels and patterns of stem cell marker, aldehyde 
dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS One 5(4):e10277. 
 
Ding Q, Yoshimitsu M, Kuwahata T, Maeda K, Hayashi T, Obara T, Miyazaki Y, 
Matsubara S, Natsugoe S, Takao S. 2012. Establishment of a highly migratory subclone 
reveals that CD133 contributes to migration and invasion through epithelial-
mesenchymal transition in pancreatic cancer. Hum Cell 25(1):1-8. 
 
Dor Y, Brown J, Martinez OI, Melton DA. 2004. Adult pancreatic beta-cells are formed 
by self-duplication rather than stem-cell differentiation. Nature 429(6987):41-6. 
 
Doyle MJ and Sussel L. 2007. Nkx2.2 regulates beta-cell function in the mature islet. 
Diabetes 56(8):1999-2007. 
 
Dror V, Nguyen V, Walia P, Kalynyak TB, Hill JA, Johnson JD. 2007. Notch signalling 
suppresses apoptosis in adult human and mouse pancreatic islet cells. Diabetologia 
50(12):2504-15. 
 
Du A, Hunter CS, Murray J, Noble D, Cai CL, Evans SM, Stein R, May CL. 2009. Islet-1 
is required for the maturation, proliferation, and survival of the endocrine pancreas. 
Diabetes 58(9):2059-69. 
 
Dubois CL, Shih HP, Seymour PA, Patel NA, Behrmann JM, Ngo V, Sander M. 2011. 
Sox9-haploinsufficiency causes glucose intolerance in mice. PLoS One 6(8):e23131. 
 
Eberhardt M, Salmon P, von Mach MA, Hengstler JG, Brulport M, Linscheid P, Seboek 
D, Oberholzer J, Barbero A, Martin I, et al. 2006. Multipotential nestin and isl-1 positive 
mesenchymal stem cells isolated from human pancreatic islets. Biochem Biophys Res 
Commun 345(3):1167-76. 
 
Ediger BN, Du A, Liu J, Hunter CS, Walp ER, Schug J, Kaestner KH, Stein R, Stoffers 
DA, Lee May C. 2014. Islet-1 is essential for pancreatic beta-cell function. Diabetes . 
86 
 
 
Formeister EJ, Sionas AL, Lorance DK, Barkley CL, Lee GH, Magness ST. 2009. 
Distinct SOX9 levels differentially mark stem/progenitor populations and 
enteroendocrine cells of the small intestine epithelium. Am J Physiol Gastrointest Liver 
Physiol 296(5):G1108-18. 
 
Froeling FE, Feig C, Chelala C, Dobson R, Mein CE, Tuveson DA, Clevers H, Hart IR, 
Kocher HM. 2011. Retinoic acid-induced pancreatic stellate cell quiescence reduces 
paracrine wnt-beta-catenin signaling to slow tumor progression. Gastroenterology 
141(4):1486,97, 1497.e1-14. 
 
Fujikura J, Hosoda K, Iwakura H, Tomita T, Noguchi M, Masuzaki H, Tanigaki K, Yabe 
D, Honjo T, Nakao K. 2006. Notch/Rbp-j signaling prevents premature endocrine and 
ductal cell differentiation in the pancreas. Cell Metab 3(1):59-65. 
 
Furuyama K, Kawaguchi Y, Akiyama H, Horiguchi M, Kodama S, Kuhara T, Hosokawa 
S, Elbahrawy A, Soeda T, Koizumi M, et al. 2011. Continuous cell supply from a Sox9-
expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 
43(1):34-41. 
 
Gao R, Ustinov J, Pulkkinen MA, Lundin K, Korsgren O, Otonkoski T. 2003. 
Characterization of endocrine progenitor cells and critical factors for their differentiation 
in human adult pancreatic cell culture. Diabetes 52(8):2007-15. 
 
Gershengorn MC, Hardikar AA, Wei C, Geras-Raaka E, Marcus-Samuels B, Raaka BM. 
2004. Epithelial-to-mesenchymal transition generates proliferative human islet precursor 
cells. Science 306(5705):2261-4. 
 
Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier 
J, Viens P, Kleer CG, Liu S, et al. 2007. ALDH1 is a marker of normal and malignant 
human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 
1(5):555-67. 
 
Glass CK, DiRenzo J, Kurokawa R, Han Z. 1991. Regulation of gene expression by 
retinoic acid receptors. DNA and Cell Biology. 10(9):623-638. 
 
Gmyr V, Kerr-Conte J, Belaich S, Vandewalle B, Leteurtre E, Vantyghem MC, Lecomte-
Houcke M, Proye C, Lefebvre J, Pattou F. 2000. Adult human cytokeratin 19-positive 
cells reexpress insulin promoter factor 1 in vitro: Further evidence for pluripotent 
pancreatic stem cells in humans. Diabetes 49(10):1671-80. 
 
Goodrich AD, Ersek A, Varain NM, Groza D, Cenariu M, Thain DS, Almeida-Porada G, 
Porada CD, Zanjani ED. 2010. In vivo generation of beta-cell-like cells from CD34(+) 
cells differentiated from human embryonic stem cells. Exp Hematol 38(6):516,525.e4. 
 
87 
 
Gopurappilly R, Bhat V, Bhonde R. 2013. Pancreatic tissue resident mesenchymal 
stromal cell (MSC)-like cells as a source of in vitro islet neogenesis. J Cell Biochem 
114(10):2240-7. 
 
Gradwohl G, Dierich A, LeMeur M, Guillemot F. 2000. Neurogenin3 is required for the 
development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci U S 
A 97(4):1607-11. 
 
Gu G, Dubauskaite J, Melton DA. 2002. Direct evidence for the pancreatic lineage: 
NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 
129(10):2447-57. 
 
Guo T, Wang W, Zhang H, Liu Y, Chen P, Ma K, Zhou C. 2011. ISL1 promotes 
pancreatic islet cell proliferation. PLoS One 6(8):e22387. 
 
Hammen PK, Allali-Hassani A, Hallenga K, Hurley TD, Weiner H. 2002. Multiple 
conformations of NAD and NADH when bound to human cytosolic and mitochondrial 
aldehyde dehydrogenase. Biochemistry 41(22):7156-68. 
 
Hao E, Tyrberg B, Itkin-Ansari P, Lakey JR, Geron I, Monosov EZ, Barcova M, Mercola 
M, Levine F. 2006. Beta-cell differentiation from nonendocrine epithelial cells of the 
adult human pancreas. Nat Med 12(3):310-6. 
 
Hess D, Li L, Martin M, Sakano S, Hill D, Strutt B, Thyssen S, Gray DA, Bhatia M. 
2003. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 
21(7):763-70. 
 
Hess DA, Meyerrose TE, Wirthlin L, Craft TP, Herrbrich PE, Creer MH, Nolta JA. 2004. 
Functional characterization of highly purified human hematopoietic repopulating cells 
isolated according to aldehyde dehydrogenase activity. Blood 104(6):1648-55. 
 
Hess DA, Wirthlin L, Craft TP, Herrbrich PE, Hohm SA, Lahey R, Eades WC, Creer 
MH, Nolta JA. 2006. Selection based on CD133 and high aldehyde dehydrogenase 
activity isolates long-term reconstituting human hematopoietic stem cells. Blood 
107(5):2162-9. 
 
Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C. 
1992. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 
68(2):397-406. 
 
Hind M, Corcoran J, Maden M. 2002. Alveolar proliferation, retinoid synthesizing 
enzymes, and endogenous retinoids in the postnatal mouse lung. different roles for aldh-1 
and raldh-2. Am J Respir Cell Mol Biol 26(1):67-73. 
 
Hisaoka M, Haratake J, Hashimoto H. 1993. Pancreatic morphogenesis and extracellular 
matrix organization during rat development. Differentiation 53(3):163-72. 
88 
 
 
Hori Y, Fukumoto M, Kuroda Y. 2008. Enrichment of putative pancreatic progenitor 
cells from mice by sorting for prominin1 (CD133) and platelet-derived growth factor 
receptor beta. Stem Cells 26(11):2912-20. 
 
Hosseini-Tabatabaei A, Jalili RB, Hartwell R, Salimi S, Kilani RT, Ghahary A. 2013. 
Embedding islet in a liquid scaffold increases islet viability and function. Can J Diabetes 
37(1):27-35. 
 
Houbracken I, de Waele E, Lardon J, Ling Z, Heimberg H, Rooman I, Bouwens L. 2011. 
Lineage tracing evidence for transdifferentiation of acinar to duct cells and plasticity of 
human pancreas. Gastroenterology 141(2):731,41, 741.e1-4. 
 
Ito T, Tajima F, Ogawa M. 2000. Developmental changes of CD34 expression by murine 
hematopoietic stem cells. Exp Hematol 28(11):1269-73. 
 
Iwasaki H, Kawamoto A, Ishikawa M, Oyamada A, Nakamori S, Nishimura H, Sadamoto 
K, Horii M, Matsumoto T, Murasawa S, et al. 2006. Dose-dependent contribution of 
CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis 
for functional regenerative recovery after myocardial infarction. Circulation 
113(10):1311-25. 
 
Jackson B, Brocker C, Thompson DC, Black W, Vasiliou K, Nebert DW, Vasiliou V. 
2011. Update on the aldehyde dehydrogenase gene (ALDH) superfamily. Hum Genomics 
5(4):283-303. 
 
Jaster R, Hilgendorf I, Fitzner B, Brock P, Sparmann G, Emmrich J, Liebe S. 2003. 
Regulation of pancreatic stellate cell function in vitro: Biological and molecular effects of 
all-trans retinoic acid. Biochem Pharmacol 66(4):633-41. 
 
Jennings RE, Berry AA, Kirkwood-Wilson R, Roberts NA, Hearn T, Salisbury RJ, 
Blaylock J, Piper Hanley K, Hanley NA. 2013. Development of the human pancreas from 
foregut to endocrine commitment. Diabetes 62(10):3514-22. 
 
Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M, Kageyama R, 
Guillemot F, Serup P, Madsen OD. 2000a. Control of endodermal endocrine 
development by hes-1. Nat Genet 24(1):36-44. 
 
Jensen J, Heller RS, Funder-Nielsen T, Pedersen EE, Lindsell C, Weinmaster G, Madsen 
OD, Serup P. 2000b. Independent development of pancreatic alpha- and beta-cells from 
neurogenin3-expressing precursors: A role for the notch pathway in repression of 
premature differentiation. Diabetes 49(2):163-76. 
 
Jeon J, Correa-Medina M, Ricordi C, Edlund H, Diez JA. 2009. Endocrine cell clustering 
during human pancreas development. J Histochem Cytochem 57(9):811-24. 
 
89 
 
Jiang J, Au M, Lu K, Eshpeter A, Korbutt G, Fisk G, Majumdar AS. 2007. Generation of 
insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 
25(8):1940-53. 
 
Jiang W, Sui X, Zhang D, Liu M, Ding M, Shi Y, Deng H. 2011. CD24: A novel surface 
marker for PDX1-positive pancreatic progenitors derived from human embryonic stem 
cells. Stem Cells 29(4):609-17. 
 
Jin L, Feng T, Shih HP, Zerda R, Luo A, Hsu J, Mahdavi A, Sander M, Tirrell DA, Riggs 
AD, et al. 2013. Colony-forming cells in the adult mouse pancreas are expandable in 
matrigel and form endocrine/acinar colonies in laminin hydrogel. Proc Natl Acad Sci U S 
A 110(10):3907-12. 
 
Joanette EA, Reusens B, Arany E, Thyssen S, Remacle RC, Hill DJ. 2004. Low-protein 
diet during early life causes a reduction in the frequency of cells immunopositive for 
nestin and CD34 in both pancreatic ducts and islets in the rat. Endocrinology 
145(6):3004-13. 
 
Joglekar MV, Joglekar VM, Joglekar SV, Hardikar AA. 2009. Human fetal pancreatic 
insulin-producing cells proliferate in vitro. J Endocrinol 201(1):27-36. 
 
Johannesson M, Stahlberg A, Ameri J, Sand FW, Norrman K, Semb H. 2009. FGF4 and 
retinoic acid direct differentiation of hESCs into PDX1-expressing foregut endoderm in a 
time- and concentration-dependent manner. PLoS One 4(3):e4794. 
 
Kadam S, Muthyala S, Nair P, Bhonde R. 2010. Human placenta-derived mesenchymal 
stem cells and islet-like cell clusters generated from these cells as a novel source for stem 
cell therapy in diabetes. Rev Diabet Stud 7(2):168-82. 
 
Kadison A, Kim J, Maldonado T, Crisera C, Prasadan K, Manna P, Preuett B, Hembree 
M, Longaker M, Gittes G. 2001. Retinoid signaling directs secondary lineage selection in 
pancreatic organogenesis. J Pediatr Surg 36(8):1150-6. 
 
Kamisawa T. 2004. Clinical significance of the minor duodenal papilla and accessory 
pancreatic duct. J Gastroenterol 39(7):605-15. 
 
Kane MA, Folias AE, Pingitore A, Perri M, Obrochta KM, Krois CR, Cione E, Ryu JY, 
Napoli JL. 2010. Identification of 9-cis-retinoic acid as a pancreas-specific autacoid that 
attenuates glucose-stimulated insulin secretion. Proc Natl Acad Sci U S A 
107(50):21884-9. 
 
Kaneto H, Miyatsuka T, Kawamori D, Yamamoto K, Kato K, Shiraiwa T, Katakami N, 
Yamasaki Y, Matsuhisa M, Matsuoka TA. 2008. PDX-1 and MafA play a crucial role in 
pancreatic beta-cell differentiation and maintenance of mature beta-cell function. Endocr 
J 55(2):235-52. 
 
90 
 
Kania G, Corbeil D, Fuchs J, Tarasov KV, Blyszczuk P, Huttner WB, Boheler KR, 
Wobus AM. 2005. Somatic stem cell marker prominin-1/CD133 is expressed in 
embryonic stem cell-derived progenitors. Stem Cells 23(6):791-804. 
 
Kawaguchi Y, Cooper B, Gannon M, Ray M, MacDonald RJ, Wright CV. 2002. The role 
of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. 
Nat Genet 32(1):128-34. 
 
Kelly OG, Chan MY, Martinson LA, Kadoya K, Ostertag TM, Ross KG, Richardson M, 
Carpenter MK, D'Amour KA, Kroon E, et al. 2011. Cell-surface markers for the isolation 
of pancreatic cell types derived from human embryonic stem cells. Nat Biotechnol 
29(8):750-6. 
 
Kiefer FW, Orasanu G, Nallamshetty S, Brown JD, Wang H, Luger P, Qi NR, Burant CF, 
Duester G, Plutzky J. 2012. Retinaldehyde dehydrogenase 1 coordinates hepatic 
gluconeogenesis and lipid metabolism. Endocrinology 153(7):3089-99. 
 
Klug S, Creech Kraft J, Wildi E, Merker HJ, Persaud TV, Nau H, Neubert D. 1989. 
Influence of 13-cis and all-trans retinoic acid on rat embryonic development in vitro: 
Correlation with isomerisation and drug transfer to the embryo. Arch Toxicol 63(3):185-
92. 
 
Kobayashi H, Spilde TL, Bhatia AM, Buckingham RB, Hembree MJ, Prasadan K, 
Preuett BL, Imamura M, Gittes GK. 2002. Retinoid signaling controls mouse pancreatic 
exocrine lineage selection through epithelial-mesenchymal interactions. Gastroenterology 
123(4):1331-40. 
 
Koblas T, Pektorova L, Zacharovova K, Berkova Z, Girman P, Dovolilova E, Karasova 
L, Saudek F. 2008. Differentiation of CD133-positive pancreatic cells into insulin-
producing islet-like cell clusters. Transplant Proc 40(2):415-8. 
 
Kopinke D, Brailsford M, Shea JE, Leavitt R, Scaife CL, Murtaugh LC. 2011. Lineage 
tracing reveals the dynamic contribution of Hes1+ cells to the developing and adult 
pancreas. Development 138(3):431-41. 
 
Kopp JL, Dubois CL, Schaffer AE, Hao E, Shih HP, Seymour PA, Ma J, Sander M. 
2011. Sox9+ ductal cells are multipotent progenitors throughout development but do not 
produce new endocrine cells in the normal or injured adult pancreas. Development 
138(4):653-65. 
 
Kordes C, Sawitza I, Gotze S, Haussinger D. 2012. Stellate cells from rat pancreas are 
stem cells and can contribute to liver regeneration. PLoS One 7(12):e51878. 
 
Krishnamurthy M, Li J, Al-Masri M, Wang R. 2008. Expression and function of 
alphabeta1 integrins in pancreatic beta (INS-1) cells. J Cell Commun Signal 2(3-4):67-
79. 
91 
 
 
Landsman L, Nijagal A, Whitchurch TJ, Vanderlaan RL, Zimmer WE, Mackenzie TC, 
Hebrok M. 2011. Pancreatic mesenchyme regulates epithelial organogenesis throughout 
development. PLoS Biol 9(9):e1001143. 
 
Lardon J, Corbeil D, Huttner WB, Ling Z, Bouwens L. 2008. Stem cell marker prominin-
1/AC133 is expressed in duct cells of the adult human pancreas. Pancreas 36(1):e1-6. 
 
Levi BP, Yilmaz OH, Duester G, Morrison SJ. 2009. Aldehyde dehydrogenase 1a1 is 
dispensable for stem cell function in the mouse hematopoietic and nervous systems. 
Blood 113(8):1670-80. 
 
Li J, Goodyer CG, Fellows F, Wang R. 2006. Stem cell factor/c-kit interactions regulate 
human islet-epithelial cluster proliferation and differentiation. Int J Biochem Cell Biol 
38(5-6):961-72. 
 
Li J, Quirt J, Do HQ, Lyte K, Fellows F, Goodyer CG, Wang R. 2007. Expression of c-
kit receptor tyrosine kinase and effect on beta-cell development in the human fetal 
pancreas. Am J Physiol Endocrinol Metab 293(2):E475-83. 
 
Li T, Su Y, Mei Y, Leng Q, Leng B, Liu Z, Stass SA, Jiang F. 2010. ALDH1A1 is a 
marker for malignant prostate stem cells and predictor of prostate cancer patients' 
outcome. Lab Invest 90(2):234-44. 
 
Li J, Feng ZC, Yeung FS, Wong MR, Oakie A, Fellows GF, Goodyer CG, Hess DA, 
Wang R. 2014. Aldehyde dehydrogenase 1 activity in the developing human pancreas 
modulates retinoic acid signalling in mediating islet differentiation and survival. 
Diabetologia 57(4):754-64. 
 
Lin HT, Chiou SH, Kao CL, Shyr YM, Hsu CJ, Tarng YW, Ho LL, Kwok CF, Ku HH. 
2006. Characterization of pancreatic stem cells derived from adult human pancreas ducts 
by fluorescence activated cell sorting. World J Gastroenterol 12(28):4529-35. 
 
Lindgren D, Bostrom AK, Nilsson K, Hansson J, Sjolund J, Moller C, Jirstrom K, 
Nilsson E, Landberg G, Axelson H, et al. 2011. Isolation and characterization of 
progenitor-like cells from human renal proximal tubules. Am J Pathol 178(2):828-37. 
 
Lonardo E, Frias-Aldeguer J, Hermann PC, Heeschen C. 2012. Pancreatic stellate cells 
form a niche for cancer stem cells and promote their self-renewal and invasiveness. Cell 
Cycle 11(7):1282-90. 
 
Lynn FC, Smith SB, Wilson ME, Yang KY, Nekrep N, German MS. 2007. Sox9 
coordinates a transcriptional network in pancreatic progenitor cells. Proc Natl Acad Sci U 
S A 104(25):10500-5. 
 
92 
 
Lyttle BM, Li J, Krishnamurthy M, Fellows F, Wheeler MB, Goodyer CG, Wang R. 
2008. Transcription factor expression in the developing human fetal endocrine pancreas. 
Diabetologia 51(7):1169-80. 
 
Ma F, Chen F, Chi Y, Yang S, Lu S, Han Z. 2012. Isolation of pancreatic progenitor cells 
with the surface marker of hematopoietic stem cells. Int J Endocrinol 2012:948683. 
 
Marchitti SA, Brocker C, Stagos D, Vasiliou V. 2008. Non-P450 aldehyde oxidizing 
enzymes: The aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol 
4(6):697-720. 
 
Martin M, Gallego-Llamas J, Ribes V, Kedinger M, Niederreither K, Chambon P, Dolle 
P, Gradwohl G. 2005. Dorsal pancreas agenesis in retinoic acid-deficient Raldh2 mutant 
mice. Dev Biol 284(2):399-411. 
 
Masini M, Marselli L, Bugliani M, Martino L, Masiello P, Marchetti P, De Tata V. 2012. 
Ultrastructural morphometric analysis of insulin secretory granules in human type 2 
diabetes. Acta Diabetol 49 Suppl 1:S247-52. 
 
McCarroll JA, Phillips PA, Santucci N, Pirola RC, Wilson JS, Apte MV. 2006. Vitamin 
A inhibits pancreatic stellate cell activation: Implications for treatment of pancreatic 
fibrosis. Gut 55(1):79-89. 
 
McDonald E, Krishnamurthy M, Goodyer CG, Wang R. 2009. The emerging role of SOX 
transcription factors in pancreatic endocrine cell development and function. Stem Cells 
Dev 18(10):1379-88. 
 
McDonald E, Li J, Krishnamurthy M, Fellows GF, Goodyer CG, Wang R. 2012. SOX9 
regulates endocrine cell differentiation during human fetal pancreas development. Int J 
Biochem Cell Biol 44(1):72-83. 
 
Merkwitz C, Pessa-Morikawa T, Lochhead P, Reinhard G, Sakurai M, Iivanainen A, 
Ricken AM. 2011. The CD34 surface antigen is restricted to glucagon-expressing cells in 
the early developing bovine pancreas. Histochem Cell Biol 135(1):59-71. 
 
Micallef SJ, Janes ME, Knezevic K, Davis RP, Elefanty AG, Stanley EG. 2005. Retinoic 
acid induces Pdx1-positive endoderm in differentiating mouse embryonic stem cells. 
Diabetes 54(2):301-5. 
 
Micallef SJ, Li X, Janes ME, Jackson SA, Sutherland RM, Lew AM, Harrison LC, 
Elefanty AG, Stanley EG. 2007. Endocrine cells develop within pancreatic bud-like 
structures derived from mouse ES cells differentiated in response to BMP4 and retinoic 
acid. Stem Cell Res 1(1):25-36. 
 
93 
 
Molotkov A and Duester G. 2003. Genetic evidence that retinaldehyde dehydrogenase 
Raldh1 (Aldh1a1) functions downstream of alcohol dehydrogenase Adh1 in metabolism 
of retinol to retinoic acid. J Biol Chem 278(38):36085-90. 
 
Moreb JS, Gabr A, Vartikar GR, Gowda S, Zucali JR, Mohuczy D. 2005. Retinoic acid 
down-regulates aldehyde dehydrogenase and increases cytotoxicity of 4-
hydroperoxycyclophosphamide and acetaldehyde. J Pharmacol Exp Ther 312(1):339-45. 
 
Moreb JS, Ucar D, Han S, Amory JK, Goldstein AS, Ostmark B, Chang LJ. 2012. The 
enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and 
ALDH2) is detected by aldefluor, inhibited by diethylaminobenzaldehyde and has 
significant effects on cell proliferation and drug resistance. Chem Biol Interact 195(1):52-
60. 
 
Muller P, Crofts JD, Newman BS, Bridgewater LC, Lin CY, Gustafsson JA, Strom A. 
2010. SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast 
cancer cells. Breast Cancer Res Treat 120(2):317-26. 
 
Muramoto GG, Russell JL, Safi R, Salter AB, Himburg HA, Daher P, Meadows SK, 
Doan P, Storms RW, Chao NJ, et al. 2010. Inhibition of aldehyde dehydrogenase expands 
hematopoietic stem cells with radioprotective capacity. Stem Cells 28(3):523-34. 
 
Naujok O and Lenzen S. 2012. A critical re-evaluation of CD24-positivity of human 
embryonic stem cells differentiated into pancreatic progenitors. Stem Cell Rev 8(3):779-
91. 
 
Niederreither K, Fraulob V, Garnier JM, Chambon P, Dolle P. 2002. Differential 
expression of retinoic acid-synthesizing (RALDH) enzymes during fetal development 
and organ differentiation in the mouse. Mech Dev 110(1-2):165-71. 
 
Nostro MC, Sarangi F, Ogawa S, Holtzinger A, Corneo B, Li X, Micallef SJ, Park IH, 
Basford C, Wheeler MB, et al. 2011. Stage-specific signaling through TGFbeta family 
members and WNT regulates patterning and pancreatic specification of human 
pluripotent stem cells. Development 138(5):861-71. 
 
Offield MF, Jetton TL, Labosky PA, Ray M, Stein RW, Magnuson MA, Hogan BL, 
Wright CV. 1996. PDX-1 is required for pancreatic outgrowth and differentiation of the 
rostral duodenum. Development 122(3):983-95. 
 
Oliver-Krasinski JM, Kasner MT, Yang J, Crutchlow MF, Rustgi AK, Kaestner KH, 
Stoffers DA. 2009. The diabetes gene Pdx1 regulates the transcriptional network of 
pancreatic endocrine progenitor cells in mice. J Clin Invest 119(7):1888-98. 
 
Oshima Y, Suzuki A, Kawashimo K, Ishikawa M, Ohkohchi N, Taniguchi H. 2007. 
Isolation of mouse pancreatic ductal progenitor cells expressing CD133 and c-met by 
flow cytometric cell sorting. Gastroenterology 132(2):720-32. 
94 
 
 
Ostrom M, Loffler KA, Edfalk S, Selander L, Dahl U, Ricordi C, Jeon J, Correa-Medina 
M, Diez J, Edlund H. 2008. Retinoic acid promotes the generation of pancreatic 
endocrine progenitor cells and their further differentiation into beta-cells. PLoS One 
3(7):e2841. 
 
Pan FC and Brissova M. 2014. Pancreas development in humans. Curr Opin Endocrinol 
Diabetes Obes 21(2):77-82. 
 
Pessina A, Bonomi A, Sisto F, Baglio C, Cavicchini L, Ciusani E, Cocce V, Gribaldo L. 
2010. CD45+/CD133+ positive cells expanded from umbilical cord blood expressing 
PDX-1 and markers of pluripotency. Cell Biol Int 34(8):783-90. 
 
Peters K, Panienka R, Li J, Kloppel G, Wang R. 2005. Expression of stem cell markers 
and transcription factors during the remodeling of the rat pancreas after duct ligation. 
Virchows Arch 446(1):56-63. 
 
Pietsch T, Nicotra MR, Fraioli R, Wolf HK, Mottolese M, Natali PG. 1998. Expression 
of the c-kit receptor and its ligand SCF in non-small-cell lung carcinomas. Int J Cancer 
75(2):171-5. 
 
Pinkse GG, Bouwman WP, Jiawan-Lalai R, Terpstra OT, Bruijn JA, de Heer E. 2006. 
Integrin signaling via RGD peptides and anti-beta1 antibodies confers resistance to 
apoptosis in islets of Langerhans. Diabetes 55(2):312-7. 
 
Piper K, Ball SG, Keeling JW, Mansoor S, Wilson DI, Hanley NA. 2002. Novel SOX9 
expression during human pancreas development correlates to abnormalities in 
campomelic dysplasia. Mech Dev 116(1-2):223-6. 
 
Piper K, Brickwood S, Turnpenny LW, Cameron IT, Ball SG, Wilson DI, Hanley NA. 
2004. Beta cell differentiation during early human pancreas development. J Endocrinol 
181(1):11-23. 
 
Prasmickaite L, Engesaeter BO, Skrbo N, Hellenes T, Kristian A, Oliver NK, Suo Z, 
Maelandsmo GM. 2010. Aldehyde dehydrogenase (ALDH) activity does not select for 
cells with enhanced aggressive properties in malignant melanoma. PLoS One 
5(5):e10731. 
 
Ramiya VK, Maraist M, Arfors KE, Schatz DA, Peck AB, Cornelius JG. 2000. Reversal 
of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. 
Nat Med 6(3):278-82. 
 
Rastinejad F, Wagner T, Zhao Q, Khorasanizadeh S. 2000. Structure of the RXR-RAR 
DNA-binding complex on the retinoic acid response element DR1. Embo j 19(5):1045-
54. 
 
95 
 
Rezania A, Bruin JE, Xu J, Narayan K, Fox JK, O'Neil JJ, Kieffer TJ. 2013. Enrichment 
of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells 
accelerates the maturation of insulin-secreting cells in vivo. Stem Cells 31(11):2432-42. 
 
Riedel MJ, Asadi A, Wang R, Ao Z, Warnock GL, Kieffer TJ. 2012. 
Immunohistochemical characterisation of cells co-producing insulin and glucagon in the 
developing human pancreas. Diabetologia 55(2):372-81. 
 
Riopel M, Stuart W, Wang R. 2013. Fibrin improves beta (INS-1) cell function, 
proliferation and survival through integrin alphavbeta3. Acta Biomater 9(9):8140-8. 
 
Rooman I, Heremans Y, Heimberg H, Bouwens L. 2000. Modulation of rat pancreatic 
acinoductal transdifferentiation and expression of PDX-1 in vitro. Diabetologia 
43(7):907-14. 
 
Rovira M, Scott SG, Liss AS, Jensen J, Thayer SP, Leach SD. 2010. Isolation and 
characterization of centroacinar/terminal ductal progenitor cells in adult mouse pancreas. 
Proc Natl Acad Sci U S A 107(1):75-80. 
 
Rubio-Cabezas O, Codner E, Flanagan SE, Gomez JL, Ellard S, Hattersley AT. 2014. 
Neurogenin 3 is important but not essential for pancreatic islet development in humans. 
Diabetologia 57(11):2421-4. 
 
Russo J, Chung S, Contreras K, Lian B, Lorenz J, Stevens D, Trousdell W. 1995. 
Identification of 4-(N,N-dipropylamino)benzaldehyde as a potent, reversible inhibitor of 
mouse and human class I aldehyde dehydrogenase. Biochem Pharmacol 50(3):399-406. 
 
Ryan EA, Lakey JR, Paty BW, Imes S, Korbutt GS, Kneteman NM, Bigam D, Rajotte 
RV, Shapiro AM. 2002. Successful islet transplantation: Continued insulin reserve 
provides long-term glycemic control. Diabetes 51(7):2148-57. 
 
Sander M, Neubuser A, Kalamaras J, Ee HC, Martin GR, German MS. 1997. Genetic 
analysis reveals that PAX6 is required for normal transcription of pancreatic hormone 
genes and islet development. Genes Dev 11(13):1662-73. 
 
Sander M, Sussel L, Conners J, Scheel D, Kalamaras J, Dela Cruz F, Schwitzgebel V, 
Hayes-Jordan A, German M. 2000. Homeobox gene Nkx6.1 lies downstream of Nkx2.2 
in the major pathway of beta-cell formation in the pancreas. Development 127(24):5533-
40. 
 
Sarkar SA, Kobberup S, Wong R, Lopez AD, Quayum N, Still T, Kutchma A, Jensen JN, 
Gianani R, Beattie GM, et al. 2008. Global gene expression profiling and histochemical 
analysis of the developing human fetal pancreas. Diabetologia 51(2):285-97. 
 
96 
 
Schaffer AE, Freude KK, Nelson SB, Sander M. 2010. Nkx6 transcription factors and 
Ptf1a function as antagonistic lineage determinants in multipotent pancreatic progenitors. 
Dev Cell 18(6):1022-9. 
 
Schaffer AE, Taylor BL, Benthuysen JR, Liu J, Thorel F, Yuan W, Jiao Y, Kaestner KH, 
Herrera PL, Magnuson MA, et al. 2013. Nkx6.1 controls a gene regulatory network 
required for establishing and maintaining pancreatic beta cell identity. PLoS Genet 
9(1):e1003274. 
 
Seaberg RM, Smukler SR, Kieffer TJ, Enikolopov G, Asghar Z, Wheeler MB, Korbutt G, 
van der Kooy D. 2004. Clonal identification of multipotent precursors from adult mouse 
pancreas that generate neural and pancreatic lineages. Nat Biotechnol 22(9):1115-24. 
 
Serafimidis I, Rakatzi I, Episkopou V, Gouti M, Gavalas A. 2008. Novel effectors of 
directed and Ngn3-mediated differentiation of mouse embryonic stem cells into 
endocrine pancreas progenitors. Stem Cells 26(1):3-16. 
 
Seymour PA, Freude KK, Tran MN, Mayes EE, Jensen J, Kist R, Scherer G, Sander M. 
2007. SOX9 is required for maintenance of the pancreatic progenitor cell pool. Proc Natl 
Acad Sci U S A 104(6):1865-70. 
 
Seymour PA, Freude KK, Dubois CL, Shih HP, Patel NA, Sander M. 2008. A dosage-
dependent requirement for Sox9 in pancreatic endocrine cell formation. Dev Biol 
323(1):19-30. 
 
Seymour PA, Shih HP, Patel NA, Freude KK, Xie R, Lim CJ, Sander M. 2012. A 
Sox9/Fgf feed-forward loop maintains pancreatic organ identity. Development 
139(18):3363-72. 
 
Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, 
Rajotte RV. 2000. Islet transplantation in seven patients with type 1 diabetes mellitus 
using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343(4):230-8. 
 
Shen CN, Marguerie A, Chien CY, Dickson C, Slack JM, Tosh D. 2007. All-trans 
retinoic acid suppresses exocrine differentiation and branching morphogenesis in the 
embryonic pancreas. Differentiation 75(1):62-74. 
 
Shih HP, Kopp JL, Sandhu M, Dubois CL, Seymour PA, Grapin-Botton A, Sander M. 
2012. A notch-dependent molecular circuitry initiates pancreatic endocrine and ductal 
cell differentiation. Development 139(14):2488-99. 
 
Shim JH, Kim SE, Woo DH, Kim SK, Oh CH, McKay R, Kim JH. 2007. Directed 
differentiation of human embryonic stem cells towards a pancreatic cell fate. 
Diabetologia 50(6):1228-38. 
 
97 
 
Simmons DL, Satterthwaite AB, Tenen DG, Seed B. 1992. Molecular cloning of a cDNA 
encoding CD34, a sialomucin of human hematopoietic stem cells. J Immunol 148(1):267-
71. 
 
Skurikhin EG, Ermakova NN, Khmelevskaya ES, Pershina OV, Krupin VA, Ermolaeva 
LA, Dygai AM. 2014. Differentiation of pancreatic stem and progenitor beta-cells into 
insulin secreting cells in mice with diabetes mellitus. Bull Exp Biol Med 156(6):726-30. 
 
Snippert HJ, van Es JH, van den Born M, Begthel H, Stange DE, Barker N, Clevers H. 
2009. Prominin-1/CD133 marks stem cells and early progenitors in mouse small 
intestine. Gastroenterology 136(7):2187,2194.e1. 
 
Solar M, Cardalda C, Houbracken I, Martin M, Maestro MA, De Medts N, Xu X, Grau 
V, Heimberg H, Bouwens L, et al. 2009. Pancreatic exocrine duct cells give rise to 
insulin-producing beta cells during embryogenesis but not after birth. Dev Cell 
17(6):849-60. 
 
St-Onge L, Sosa-Pineda B, Chowdhury K, Mansouri A, Gruss P. 1997. Pax6 is required 
for differentiation of glucagon-producing alpha-cells in mouse pancreas. Nature 
387(6631):406-9. 
 
Stafford D, White RJ, Kinkel MD, Linville A, Schilling TF, Prince VE. 2006. Retinoids 
signal directly to zebrafish endoderm to specify insulin-expressing beta-cells. 
Development 133(5):949-56. 
 
Stanger BZ, Tanaka AJ, Melton DA. 2007. Organ size is limited by the number of 
embryonic progenitor cells in the pancreas but not the liver. Nature 445(7130):886-91. 
 
Storms RW, Trujillo AP, Springer JB, Shah L, Colvin OM, Ludeman SM, Smith C. 
1999. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde 
dehydrogenase activity. Proc Natl Acad Sci U S A 96(16):9118-23. 
 
Storms RW, Green PD, Safford KM, Niedzwiecki D, Cogle CR, Colvin OM, Chao NJ, 
Rice HE, Smith CA. 2005. Distinct hematopoietic progenitor compartments are 
delineated by the expression of aldehyde dehydrogenase and CD34. Blood 106(1):95-
102. 
 
Street CN, Lakey JR, Shapiro AM, Imes S, Rajotte RV, Ryan EA, Lyon JG, Kin T, Avila 
J, Tsujimura T, et al. 2004. Islet graft assessment in the edmonton protocol: Implications 
for predicting long-term clinical outcome. Diabetes 53(12):3107-14. 
 
Sugiyama T, Rodriguez RT, McLean GW, Kim SK. 2007. Conserved markers of fetal 
pancreatic epithelium permit prospective isolation of islet progenitor cells by FACS. Proc 
Natl Acad Sci U S A 104(1):175-80. 
 
98 
 
Sussel L, Kalamaras J, Hartigan-O'Connor DJ, Meneses JJ, Pedersen RA, Rubenstein JL, 
German MS. 1998. Mice lacking the homeodomain transcription factor Nkx2.2 have 
diabetes due to arrested differentiation of pancreatic beta cells. Development 
125(12):2213-21. 
 
Suzuki A, Nakauchi H, Taniguchi H. 2004. Prospective isolation of multipotent 
pancreatic progenitors using flow-cytometric cell sorting. Diabetes 53(8):2143-52. 
 
Tulachan SS, Doi R, Kawaguchi Y, Tsuji S, Nakajima S, Masui T, Koizumi M, Toyoda 
E, Mori T, Ito D, et al. 2003. All-trans retinoic acid induces differentiation of ducts and 
endocrine cells by mesenchymal/epithelial interactions in embryonic pancreas. Diabetes 
52(1):76-84. 
 
Van de Casteele M, Leuckx G, Cai Y, Yuchi Y, Coppens V, De Groef S, Van Gassen N, 
Baeyens L, Heremans Y, Wright CV, et al. 2014. Partial duct ligation: Beta-cell 
proliferation and beyond. Diabetes 63(8):2567-77. 
 
Villasenor A, Chong DC, Cleaver O. 2008. Biphasic Ngn3 expression in the developing 
pancreas. Dev Dyn 237(11):3270-9. 
 
Wang RN, Kloppel G, Bouwens L. 1995. Duct- to islet-cell differentiation and islet 
growth in the pancreas of duct-ligated adult rats. Diabetologia 38(12):1405-11. 
 
Wang R, Li J, Yashpal N. 2004. Phenotypic analysis of c-kit expression in epithelial 
monolayers derived from postnatal rat pancreatic islets. J Endocrinol 182(1):113-22. 
 
Wobus AM, Kaomei G, Shan J, Wellner MC, Rohwedel J, Ji G, Fleischmann B, Katus 
HA, Hescheler J, Franz WM. 1997. Retinoic acid accelerates embryonic stem cell-
derived cardiac differentiation and enhances development of ventricular cardiomyocytes. 
J Mol Cell Cardiol 29(6):1525-39. 
 
Wood IS and Trayhurn P. 2003. Glucose transporters (GLUT and SGLT): Expanded 
families of sugar transport proteins. Br J Nutr 89(1):3-9. 
 
Wu Y, Li J, Saleem S, Yee SP, Hardikar AA, Wang R. 2010. c-kit and stem cell factor 
regulate PANC-1 cell differentiation into insulin- and glucagon-producing cells. Lab 
Invest 90(9):1373-84. 
 
Yashpal NK, Li J, Wang R. 2004. Characterization of c-kit and nestin expression during 
islet cell development in the prenatal and postnatal rat pancreas. Dev Dyn 229(4):813-25. 
 
Ye DZ, Tai MH, Linning KD, Szabo C, Olson LK. 2006. MafA expression and insulin 
promoter activity are induced by nicotinamide and related compounds in INS-1 
pancreatic beta-cells. Diabetes 55(3):742-50. 
 
99 
 
Yin SJ, Cheng TC, Chang CP, Chen YJ, Chao YC, Tang HS, Chang TM, Wu CW. 1988. 
Human stomach alcohol and aldehyde dehydrogenases (ALDH): A genetic model 
proposed for ALDH III isozymes. Biochem Genet 26(5-6):343-60. 
 
Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, 
Kearney J, Buck DW. 1997. AC133, a novel marker for human hematopoietic stem and 
progenitor cells. Blood 90(12):5002-12. 
 
Zacchigna S, Oh H, Wilsch-Brauninger M, Missol-Kolka E, Jaszai J, Jansen S, Tanimoto 
N, Tonagel F, Seeliger M, Huttner WB, et al. 2009. Loss of the cholesterol-binding 
protein prominin-1/CD133 causes disk dysmorphogenesis and photoreceptor 
degeneration. J Neurosci 29(7):2297-308. 
 
Zhang WJ, Xu SQ, Cai HQ, Men XL, Wang Z, Lin H, Chen L, Jiang YW, Liu HL, Li 
CH, et al. 2013. Evaluation of islets derived from human fetal pancreatic progenitor cells 
in diabetes treatment. Stem Cell Res Ther 4(6):141. 
 
Zhao M, Amiel SA, Christie MR, Muiesan P, Srinivasan P, Littlejohn W, Rela M, Arno 
M, Heaton N, Huang GC. 2007. Evidence for the presence of stem cell-like progenitor 
cells in human adult pancreas. J Endocrinol 195(3):407-14. 
 
Zhou F, Mu YD, Liang J, Liu ZX, Chen HS, Zhang JF. 2014. Expression and prognostic 
value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma. Oncol Lett 
7(2):507-12. 
 
  
100 
 
 
 
 
 
 
 
Appendices 
 
  
101 
 
Appendix A: Use of Human Participants- Ethics Approval Form  
 
102 
 
Appendix B: Classification II Laboratory Approval Form  
 
  
University of Western Ontario
Permit Summary
Permit # BIO-LHRI-0046
Wang, Rennian 
Department Physiology
Phone 5196858500 Ext. 55098     
Email rwang@uwo.ca
Approval Date Apr 25, 2014 Expiration Date Apr 24, 2017
BioSafety Officer's Signature
Permit Holder
Classification 2       
Building Room Room Area Lab Phone Ext. Level
organs and tissues (unpreserved), organs and tissues (preserved)
Human (primary), fetal pancreas and duodenum, Rodent (primary), mouse pancreatic islets, human (established), PANC-1, HEK293, 
Rodent (established), INS-1, AR42J
B6 mice
Streptozotocin, Tamoxifen
Organism
Cell
Human
GMO
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Health certificates will be required.
REQUIREMENTS/COMMENTS
Please ensure that individual(s) performing procedures on live animals, as described in this
protocol, are familiar with the contents of this document.
The holder of this Animal Use Protocol is responsible to ensure that all associated safety
components (biosafety, radiation safety, general laboratory safety) comply with institutional
safety standards and have received all necessary approvals. Please consult directly with your
institutional safety officers.
Submitted by: Kinchlea, Will D
on behalf of the Animal Use Subcommittee
Subject:
To:
Cc:
Date:
From:
eSirius Notification - Annual Protocol Renewal
APPROVED by the AUS 2008-038-04::6
rwang@uwo.ca 
auspc@uwo.ca, auspc@uwo.ca 
11/28/14 11:51 AM
esiriusadmin@uwo.ca, (eSiriusWebServer) 
https://iwc.uwo.ca/iwc_static/layout/shell.html?lang=en&2-4.0...
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Appendix E: Immunofluorescence staining for positive and negative antibody 
controls. ALDHhi sorted populations were stained for: Rabbit anti-SOX9 antibody and 
FITC-conjugated anti-rabbit IgG (+ve control); and FITC-conjugated anti-rabbit IgG only 
(2° –ve control). Nuclei populations are stained in blue (DAPI). Scale bar, 15 µm. 
Magnification, 40x 
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Appendix F: Melting curves (a) and derivative melting curves (b) of qRT-PCR 
products. Curves for 18S (left) and SOX9 (right) demonstrate the amplification of target 
sequences in qRT-PCR reactions.  
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